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ABSTRACT 
SIRIN YAEMSIRI: Serum Fatty Acids and Risk of Ischemic Stroke in Postmenopausal 
Women 
(Under the direction of Ka He) 
 
Ischemic stroke is a major cause of death and disability among postmenopausal 
women. One of the risk factors of ischemic stroke is diet, including dietary fat intake. 
It has been established that intake of trans and saturated fatty acids are positively 
associated with coronary heart disease, whereas monounsaturated and polyunsaturated 
fatty acids are inversely associated. Despite the expectation that these associations would 
be consistent for ischemic stroke, this has not been the case in studies using participant 
reported measures of fatty acid intake. Rather, studies using biomarkers of fatty acid intake, 
such as serum, have had more success in finding the expected associations. This 
dissertation attempts to explain these inconsistent results through two aims.  
The first aim was to estimate the correlations between individual serum fatty acids and 
fatty acid intakes, which may partially explain previous inconsistent results from studies 
using different fatty acid assessment methods. The participants were 925 women from the 
Women’s Health Initiative Observational Study (WHI-OS) of postmenopausal US women. 
Serum fatty acid composition was determined from a fasting serum sample collected at 
enrollment. Fatty acid intakes were measured using a 122-item food frequency 
questionnaire also at enrollment. Individual fatty acids with the highest Spearman rank 
correlations between serum and dietary intake were docosapentaenoic (DHA), 
eicosapentaenoic (EPA), and 18:1t fatty acid. Serum saturated, monounsaturated, and n6 
polyunsaturated fatty acids were not correlated with the corresponding intake measures. 
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This work highlights the need for further research to find suitable biomarkers for intakes of 
individual fatty acids.  
The second aim was to estimate the association between individual serum fatty acids 
and incidence of ischemic stroke and ischemic stroke subtypes. We conducted a case-
control study nested in the WHI-OS. Incident ischemic stroke cases were centrally 
adjudicated, classified by etiologic subtype, and matched (1:1) to controls for a total of 964 
case-control pairs. Serum linelaidic, palmitic, and oleic acids were associated with higher 
incidence of ischemic stroke, while serum EPA, docosapentaenoic (DPA), DHA, and 
arachidonic acids were associated with lower incidence. These associations were generally 
consistent for atherothrombotic and lacunar, but not cardioembolic, stroke. This work 
highlights the importance of individual fatty acids in the development of particular subtypes 
of ischemic stroke. 
This dissertation brings to attention the areas for future research. First, there is a need 
to find suitable biomarkers for individual fatty acid intakes. Second, future studies should 
explore the associations between individual fatty acids and disease, not only focusing on 
fatty acid groups. Third, the heterogeneous etiology of ischemic stroke suggests that 
ischemic stroke subtypes should be examined separately. Lastly, public health initiatives to 
increase the intake of DHA and EPA and reduce intake of 18:1t may reduce the incidence of 
ischemic stroke among postmenopausal US women. 
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I. INTRODUCTION 
Ischemic stroke and coronary heart disease (CHD) are both atherosclerotic disorders 
and share many of the same risk factors, but surprisingly limited epidemiologic data indicate 
that dietary fat intake may have different associations with ischemic stroke than with CHD. It 
has been well established that trans and saturated fats are positively associated with 
coronary heart disease, whereas monounsaturated and polyunsaturated fats are inversely 
associated with CHD. Despite the expectation that these associations would be consistent 
for ischemic stroke, several large cohort studies using participant reported measures of fatty 
acid intake reported null or inverse associations between saturated fat intake and ischemic 
stroke. Rather, case-control studies using biomarkers of fatty acid intake, such as serum, 
have had more success in finding the expected associations with ischemic stroke. In this 
dissertation, we investigated possible explanations for the inconsistencies across (i) cohort 
studies of dietary fat intake and CHD versus ischemic stroke and (ii) studies measuring 
dietary fat intake through participant report versus fatty acid biomarkers. 
The inconsistencies across cohort studies could be due to individual fatty acids having 
different associations with ischemic stroke. We hypothesized that fatty acids may play a role 
in the development of some ischemic stroke subtypes, but not others. Fatty acids have a 
powerful effect on serum cholesterol and there is evidence that serum cholesterol may play 
a role in the development of some ischemic stroke subtypes, but not others. Therefore, 
examining ischemic stroke as a composite outcome would not be appropriate and would 
attenuate expected associations. In addition, examining ischemic stroke subtypes based on 
etiology may provide insight on the mechanism  of ischemic stroke development. Despite 
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these motivations, data on ischemic stroke subtypes were available in few studies. 
Statistical power was limited for the studies where such data were available. 
The inconsistencies between studies measuring dietary fat intake through participant 
report versus fatty acid biomarkers could be due to their respective methods of measuring 
dietary fat intake. The cohort studies estimated fatty acid intake through participant report 
and food frequency questionnaires (FFQ), a measure that is subject to substantial error. 
Participants may be reluctant or unable to report their habitual food intake accurately. 
Further, nutritional databases that convert foods to nutrients may not be updated to reflect 
the continuously changing fatty acid content of food items. Measurement of the composition 
of fatty acids in serum in case-control studies has been proposed as an alternative to the 
FFQ. However, serum fatty acids reflect metabolic processes and endogenous synthesis of 
fatty acids after intake. Therefore, it is unclear which serum fatty acids correlate with long-
term fat intake as measured by the FFQ among postmenopausal US women. Few studies 
have examined the correlations between serum fatty acids and fatty acid intakes in this 
population.  
Another difference between the cohort and case-control studies is that the cohort studies 
focused on fat intake groups. However, individual fatty acids within the same group may 
have different, and sometimes opposing, effects on cardiovascular diseases. The effect of 
grouping these fatty acids may dilute possible associations for individual fatty acids and 
ischemic stroke. Previous studies that were able to examine individual fatty acids were 
limited by statistical power, with less than 150 cases of ischemic stroke.   
 To address these concerns, the aims of the proposed study were (1) to examine the 
correlations between serum fatty acids and fatty acid intakes and (2) to estimate the 
associations between individual serum fatty acids and ischemic stroke and its subtypes. We 
used data from the Women’s Health Initiative Observational Study (WHI-OS) of 
postmenopausal US women.  
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II. SPECIFIC AIMS 
 
We hypothesized that serum fatty acids that are not endogenously synthesized in large 
amounts (polyunsaturated fatty acids, trans fatty acids, and odd-numbered saturated fatty 
acids) would have higher correlations with fatty acid intakes than other serum fatty acids. 
 
To test this hypothesis, we estimated the correlations between serum fatty acids and 
fatty acid intakes (Aim 1). 
 
We hypothesized that higher levels of serum saturated (myristic, 14:0; and palmitic, 16:0) 
and trans fatty acids (18:1t; and linelaidic, 18:2tt) were associated with increased incidence 
of ischemic stroke.  
 
We hypothesized that higher levels of n3 (alpha-linolenic acid, 18:3n3; EPA, 20:5n3; DPA, 
22:5n3; and DHA, 22:6n3) and n6 (linoleic acid, 18:2n6; and arachidonic acid, 20:4n6) 
polyunsaturated fatty acids were associated with decreased incidence of ischemic stroke. 
 
We hypothesized that associations for total ischemic stroke would be consistent for 
atherothrombotic stroke, but not other types of ischemic stroke. 
 
To test these hypotheses, we estimated the associations between individual serum 
fatty acids and ischemic stroke and ischemic stroke subtypes (Aim 2). 
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III. SIGNIFICANCE  
 Ischemic stroke is a major cause of death and disability among postmenopausal women. 
There are no reliable warning signs and treatment is difficult and time-limited emphasizing 
the importance of the primary prevention of ischemic stroke. In contrast to CHD, which is 
directly associated with dietary fat intake through its effect on blood cholesterol, there is no 
clear association between types of dietary fat intake and ischemic stroke. Cohort studies 
that have examined this association may be limited by their dietary fat intake assessment, 
their examination of types of fat as a composite exposure, and total ischemic stroke as a 
composite outcome. Case-control studies of biomarkers of dietary fat intake were limited by 
the small number of ischemic stroke events. There is an opportunity to examine the 
association between the composition of serum fatty acids and ischemic stroke subtypes 
among postmenopausal women to address these concerns. 
A. High burden of stroke among postmenopausal women 
In the US, stroke is the fourth leading cause of death, behind heart disease, cancer, and 
chronic lower respiratory disease, and is responsible for over 134 thousand deaths 
annually (Roger et al., 2012). One in five middle-aged individuals who experience a first 
stroke will die within one year. Of those who survive, a quarter will require institutional care 
and 20% to 50% will be permanently disabled. Therefore, the key to reducing stroke 
mortality and morbidity is not treatment, but primary prevention. This dissertation focuses on 
ischemic strokes, which make up 87% of incident strokes in the US. 
Although age-specific stroke incidence and mortality rates are higher in men than 
women, stroke affects a greater number of women, a trend that is expected to 
continue (Reeves et al., 2008). Each year, 55 thousand more women than men have a 
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stroke, and women make up 60% of annual stroke mortality (Roger et al., 2012). Over the 
past half century, the 30-day stroke mortality rate has not improved in women (Carandang et 
al., 2006). After a stroke, a greater proportion of women than men have moderate to severe 
disability at discharge and women have a lower probability of achieving independence. 
The primary reason that the burden of stroke is higher in women is that they live about 7 
years longer than men. Stroke typically occurs at a later age, the majority occurring after 
menopause in women (Roger et al., 2012), its risk doubling every decade of life after age 
55. However, even comparing women and men in the same age group, women still have 
higher risk of stroke than men. In a nationally representative survey, women age 45 to 54 
years of age were more than twice as likely as men in the same age group to have suffered 
a stroke (Towfighi et al., 2007). In addition, factors other than age have been linked with 
increased risk of stroke in women, such as use of hormone replacement therapy (Viscoli et 
al., 2001; Rossouw et al., 2002; Wassertheil-Smoller et al., 2003; Hendrix et al., 2006), 
experiencing early menopause (Lisabeth et al., 2009), pregnancy (Kittner et al., 1996), and 
atrial fibrillation (a stronger stroke risk factor in women than men) (Wolf et al., 1991). Women 
and older women specifically are underrepresented in stroke studies. These statistics point 
to a need to study the etiology of stroke in older women, who share a disproportional burden 
of stroke risk.  
B. Opposite trends in CHD and stroke mortality 
 Ischemic stroke and CHD are both atherosclerotic disorders and share many of the 
same risk factors, but they seem to differ in their associations with dietary fat intake. Trans 
and saturated fat intakes are positively associated with CHD and monounsaturated and 
polyunsaturated fat intakes are inversely associated with CHD through their respective 
effects on serum cholesterol and atherosclerosis. The associations between dietary fat 
intake and ischemic stroke are not as clear.  
 The association between dietary fat intake and ischemic stroke has been debated since 
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the 1950s when Tavia Gordon observed that CHD mortality rates were higher and vascular 
lesions affecting the central nervous system were lower among US whites than 
Japanese (Gordon, 1957). Reducing the possibility that these trends were due to genetic 
makeup, a similar gradient was found where Japanese living in the US had higher CHD 
mortality than those living in Japan, and again the inverse was true for vascular lesions 
(Figure 1). Japanese living in Hawaii occupied the intermediate position in both cases. 
Concluding that the opposite trends were due to environmental or cultural differences, 
Gordon wrote, “We are faced with a serious medical puzzle…What mechanism would 
diminish the effect of atherosclerosis of the coronary artery while increasing its effect on the 
cerebrovascular system?” 
Saturated fat intake was proposed to explain the opposite trends of CHD and stroke 
mortality found in Japan and the US. The Ni-Hon-San study confirmed Gordon’s findings 
using standardized criteria to classify causes of death and noted that CHD mortality rates 
increased dramatically with higher saturated fat intake, while stroke rates followed the 
opposite pattern (Kato et al., 1973; Worth et al., 1975). Using data from 21 industrialized 
countries, Renaud summarized that dairy fat, which is rich in saturated fat, was positively 
related to CHD mortality. In the same countries, an inverse association between intake of 
dairy products and stroke mortality in men and women was observed (Figure 2) (Renaud, 
2001). Nevertheless, a positive correlation between saturated fat intake and stroke mortality 
was reported in a survey performed in 17 countries (Sasaki et al., 1995). While ecologic 
studies can explore broad geographic and temporal differences in dietary habits and 
generate hypotheses, ecologic data are prone to be confounded by various factors.  
C. Dietary fat intake and ischemic stroke 
 To address the possible confounding in the ecologic data, the associations between 
dietary fat intake and ischemic stroke were examined next in cohort studies. These cohort 
studies used FFQs, a participant reported measure of fatty acid intake. However, they did 
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not find the expected associations between saturated, monounsaturated, polyunsaturated 
fat intake and ischemic stroke. In addition, few studies examined trans fat intake.  
 Kagan and colleagues observed an inverse relation between total fat intake and incident 
ischemic stroke in 7,895 male Japanese or Japanese Americans living in Hawaii (154 
thromboembolic strokes) over 10 years of follow-up (Kagan et al., 1985). In addition, Gillman 
and colleagues followed 832 middle-aged men (61 ischemic strokes) in the Framingham 
Heart Study for 20 years and found that intakes of total, saturated, and monounsaturated 
fat, but not polyunsaturated fat, were inversely associated with risk of ischemic stroke. 
 Subsequent cohort studies included a greater number of ischemic strokes, but did not 
detect significant associations. A 15-year follow-up study of 954 male and 1,329 female 
Japanese patients (75 cerebral infarctions) reported statistically nonsignificant associations 
for total fat and types of fat (Seino et al., 1997). However, the direction of the associations 
suggested that they were inverse for total, saturated, and monounsaturated fat and positive 
for polyunsaturated fat. Another cohort study of Japanese men and women (60 fatal cerebral 
infarction) observed that animal fat intake, mostly saturated fat, was inversely associated 
with cerebral infarction death, but found no significant associations for total, 
monounsaturated, or polyunsaturated fat intake (Sauvaget et al., 2004). Two large cohort 
studies of male and female healthcare professionals, the Health Professionals Follow-up 
Study and the Nurses’ Health Study with 455 and 385 cases of ischemic stroke, 
respectively, did not find significant associations for total fat, cholesterol, or specific types of 
fat and ischemic stroke after adjustment for potential confounders and major lifestyle 
variables (Iso, Stampfer, et al., 2001; He et al., 2003). A large cohort study of 
postmenopausal US women also did not find significant associations for total, saturated, 
monounsaturated, or polyunsaturated fat intakes and ischemic stroke (Yaemsiri et al., 2012 
[in press]). However, investigators did report a significant positive association between trans 
fat intake and ischemic stroke that was driven by lacunar stroke. Lacunar strokes are 
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strokes that occur in the smaller intracerebral arteries of the brain and are primarly caused 
by high blood pressure. A detailed description of lacunar strokes may be found in Section IV. 
D. 3. 
 The results of the cohort studies described here were generally not consistent with the 
expected associations based on CHD studies. We suspected that the inconsistent results 
were due to not examining ischemic stroke subtypes and not examining fatty acids 
individually. Assuming that serum cholesterol and development of atherosclerosis are the 
likely mediators of the association between dietary fat intake and ischemic stroke, then 
combining strokes with and without an atherogenic basis would not be appropriate. There is 
evidence that the associations between dietary fat intake and ischemic stroke are not 
consistent across ischemic stroke subtypes (Iso et al., 2002; Yaemsiri et al., 2012 [in press]). 
However, most of these cohort studies only examined ischemic stroke as a composite 
outcome. In addition, there is evidence that individual fatty acids, even within the same 
group, may have different effects on the risk of cardiovascular disease. However, these 
cohort studies only examined types of fat, not individual fatty acid intakes.  
D. Biomarkers of Fatty Acid Intake and Ischemic Stroke 
 Case-control studies using biomarkers of fatty acid intake were able to examine fatty 
acids individually. These studies reported associations between fatty acid biomarkers and 
ischemic stroke that were generally consistent with CHD studies. However, these case-
control studies were limited by statistical power. None included more than 125 cases of 
ischemic stroke. The low statistical power increased the chance that an association between 
a fatty acid and ischemic stroke would not be detected. In addition, none of these case-
control studies examined trans fatty acids. 
 In the 1980s, Miettinen and colleagues conducted a nested case-control study to explore 
the difference in serum fatty acid concentration measured at baseline between ischemic 
stroke patients and healthy controls (Miettinen et al., 1986). They found that n6 
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polyunsaturated fatty acids, especially dihomo-gamma-linolenic acid (DGLA, 20:3n6), were 
lower in stroke patients than controls. DGLA This study included only 9 cases of cerebral 
artery thrombosis in males. To maximize statistical power, investigators did not control for 
confounding in multivariable models, but matched cases to controls on several factors: age, 
body weight, serum cholesterol and triglyceride concentrations, blood pressure, smoking, 
and glucose tolerance at baseline. Most, but not all, of subsequent case-control studies 
supported the inverse association between n6 polyunsaturated fatty acids and ischemic 
stroke. 
 In two studies (with 56 and 89 cases of ischemic stroke) that measured the fatty acid 
composition of red blood cell membranes, researchers found that linoleic acid, 
docosapenaenoic acid (DPA) and docosahexaenoic acid (DHA), and oleic acids were 
inversely associated with ischemic stroke (Ricci et al., 1987; Ricci et al., 1997). However, in 
another study of 18 cases of cerebral thrombosis, Bucalossi and Mori did not report a 
significant association for adipose tissue linoleic acid and cerebral thrombosis (Bucalossi & 
Mori, 1972). They did find significant positive associations for palmitic and stearic acids and 
an inverse association for 7-hexadecenoic acid.  
 Tilvis and colleagues found that age and the type of biomarker can modify the 
associations between fatty acids and ischemic stroke. Twenty-six middle-aged male cases 
of ischemic stroke were associated with higher concentrations of serum saturated, 
monounsaturated, and n3 polyunsaturated fatty acids and lower concentrations of n6 
polyunsaturated fatty acids compared with controls. However, platelet fatty acid 
concentrations were not found to be associated with ischemic stroke. Among 14 younger 
male cases of ischemic stroke, none of the serum fatty acids were associated with ischemic 
stroke. However, higher concentrations of platelet linoleic acid and lower concentrations of 
platelet arachidonic acid were associated with ischemic stroke. These results suggest that 
the fatty acid biomarker used and the age of the study population are important variables to 
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consider in studying the association between fatty acids and ischemic stroke. None of the 
biomarker studies described here included more than 90 cases of ischemic stroke. 
 The largest study of serum fatty acids and ischemic strokes to date included 122 cases 
of ischemic stroke and 366 matched controls nested in a Japanese population-based 
cohort (Iso et al., 2002). To our knowledge, this is the only study of biomarkers of fatty acids 
that examined ischemic stroke subtypes. Iso and colleagues reported that serum saturated 
fatty acids were positively associated with incidence of ischemic stroke, while serum linoleic 
acid was associated with decreased incidence of ischemic stroke. These associations were 
largely driven by lacunar stroke, this subtype comprising 95 of the 122 ischemic strokes. 
Investigators did not find significant associations for marine n3 polyunsaturated fatty acids. 
However, they note that the Japanese have quite high levels of these fatty acids. Those with 
the lowest concentrations of marine n3 polyunsaturated fatty acids in this population may 
have already reached the level that provides cardioprotective effects, so that a significant 
association was not observed (Iso, Rexrode, et al., 2001; He et al., 2002). Investigators did 
not examine serum trans fat and acknowledged the uncertainty of the associations for other 
ischemic stroke subtypes. Further exploration is needed on the association between types 
of fat and ischemic stroke subtypes. 
E. Gaps in the Literature 
There are several gaps in the literature examining fatty acids and ischemic stroke. First, 
measurement of fatty acid intake though participant report in the cohort studies is subject to 
considerable systematic error. The effect of systematic error – if individuals with high fat 
intake are more likely to underreport fat intake (Millen et al., 2009) and are associated with 
high risk of stroke – is to bias associations toward the null. Measurement of fatty acid 
concentrations in tissue may have less systematic error, allowing us to detect associations 
with ischemic stroke. Second, most cohort studies examined fat intake groups, but not 
individual fatty acids. These studies were not able to examine fatty acids individually 
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because they measured fat intake through participant report (e.g. FFQ and 24-hour recall).  
These methods result in high correlations among individual fatty acids within the same 
group, making distinguishing their relations with cardiovascular disease risk difficult (Hu et 
al., 2001). Third, only three studies examined associations for ischemic stroke subtypes, 
despite the possibility that associations between fatty acids and ischemic stroke may not be 
consistent across all ischemic stroke subtypes (Iso, Stampfer, et al., 2001; Iso et al., 2002; 
Yaemsiri et al., 2012 [in press]). In the Nurses’ Health Study, there were less than 50 cases 
for each ischemic stroke subtype (Iso, Stampfer, et al., 2001). Likely statistical power was 
too low to detect associations with ischemic stroke subtypes in this study. Fourth, only three 
studies have examined trans fatty acids in relation to ischemic stroke (Iso, Stampfer, et al., 
2001; He et al., 2003; Yaemsiri et al., 2012 [in press]); none of these studies used a 
biomarker of fatty acid intake.
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IV. INNOVATION 
A. Introduction 
 Four changes in the approach of studying the associations between dietary fat intake 
and ischemic stroke may shed new light on these associations. First, previous studies using 
FFQs to measure dietary fat intake were subject to error in the self-report, underreporting, 
and changing fat content of foods. We proposed to use serum fatty acids as an objective 
biomarker for dietary fat intake. Second, previous studies reported null associations 
between dietary fat groups and ischemic stroke. It is possible that the grouping the fatty 
acids diluted the associations between individual fatty acids and ischemic stroke. We 
proposed to examine the associations for individual fatty acids, including individual trans 
fatty acids. Third, ischemic stroke is a heterogeneous condition; examining ischemic stroke 
as a composite outcome may not be appropriate and would attenuate expected 
associations. Previous studies did not have information on ischemic stroke subtypes or were 
underpowered to examine subtype specific associations. We proposed to examine ischemic 
stroke subtypes. Fourth, risk of stroke in women dramatically increases after menopause. 
Postmenopausal women have been underrepresented in ischemic stroke studies, even 
though stroke is a major health issue for older women. We proposed to examine these 
associations among a cohort of postmenopausal women.  
B. Serum Fatty Acids 
1. Limitations of self-reported measures of dietary intake 
 Fatty acid intake and metabolism play important roles in the development of 
cardiovascular disease (Hu et al., 2001). One of  the challenges in studying individual fatty 
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acid intake is measurement (Arab, 2003). There are two primary methods of measuring fatty 
acid intake: directly through food chemistry or participant self-report (e.g., food frequency 
questionnaire [FFQ]) and indirectly through the use of a biological marker (Willett, 1998). 
 The food frequency questionnaire (FFQ) dietary assessment tool is widely used in large 
cohort studies for ease of administration and affordability, but has some limitations. The FFQ 
requires identification of detailed information, such as the frequency and portion size of 
intake of a particular food over a several months. Participants may be unable to accurately 
report their intake or likely to underreport intake of certain foods. Americans are large 
consumers of processed foods, but are not usually aware of the nutrient content of these 
foods (e.g. “hidden fats”). In addition, the fat content of food items has changed considerably 
over time (e.g. margarine). Databases used to derive nutrient information from foods may 
not reflect the actual nutrient content. Therefore, measurement of fatty acid concentrations 
in tissues (serum, adipose, and red blood cells) have been proposed as an objective method 
of indirectly measuring fatty acid intake (Freedman et al., 2010). 
2. Biomarkers of dietary fat intake 
 Tissue biomarkers of dietary fat intake include serum/plasma, red blood cell membranes, 
and adipose tissue. Adipose tissue and red blood cells are considered better long-term 
biomarkers based on the slower turnover rate of fatty acids in these tissues compared with 
serum  (Skeaff et al., 2006). However, adipose tissue aspiration is not widely acceptable to 
healthy subjects. Tissue aspiration is more invasive and painful than a blood draw. Healthy 
participants may be reluctant to undergo tissue aspiration without a therapeutic purpose. 
Epidemiologic studies using this procedure are open to the biases associated with limited 
participation. Compared with adipose tissue aspiration, serum samples are relatively easy to 
obtain (Skeaff et al., 2006). Compared with red blood cell fatty acids, serum fatty acids are 
less prone to degradation during storage (Glatz et al., 1989; Romon et al., 1995). In this 
dissertation, we examined serum fatty acids as a biomarker of fatty acid intake. 
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3. Serum Fatty Acids and CVD Risk Factors and Outcomes 
 Studies examining the correlation between serum fatty acids and cardiovascular risk 
factors and outcomes support the utility of serum fatty acids. Serum cholesteryl ester fatty 
acid concentrations are correlated with serum lipid levels (Knuiman et al., 1980; Sandker et 
al., 1993; Rosseneu et al., 1994; Mensink et al., 2003). Serum fatty acids have successfully 
predicted common health outcomes in observational studies, such as diabetes (Lovejoy et 
al., 2001; Wang et al., 2003; Lindgarde et al., 2006), cardiovascular disease (Miettinen et al., 
1982; Simon et al., 1995; Laaksonen et al., 2005), premature death from cancer (Zureik et 
al., 1995), and Alzheimer’s disease (Tully et al., 2003). 
4. Correlations depend on the population under study 
 Correlations between serum fatty acid concentrations and fatty acid intakes may differ by 
the population under study (Baylin et al., 2002; Giltay et al., 2004; Kawabata et al., 2011). 
For example, one correlation study of adipose tissue conducted in Costa Rica reported high 
correlations for 18:1t and linelaidic acid due to the high intake of partially hydrogenated 
soybean oil in that population (Baylin et al., 2002). However, only a few studies have 
examined the correlations of fatty acids specifically among postmenopausal women. One 
study of serum fatty acids included a wide age range of both pre- and postmenpausal 
women (range: 43 to 69 years) (Sun et al., 2007). Another study of postmenopausal women 
examined adipose tissue fatty acids, but not serum (London et al., 1991). We can contribute 
to this literature by exploring the correlations between the serum fatty acids and dietary fat 
intakes among postmenopausal women. 
5. Correlation between serum fatty acids and fatty acid intakes 
 Serum fatty acids differ from the direct measurement of fatty acid intake due to 
absorption, transport, uptake, metabolism, and excretion of fatty acids in diet (Arab & Akbar, 
2002). Given these differences, comparisons between serum fatty acids and fatty acid 
intakes conducted even within the same population are not expected to yield high 
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correlations, although the fatty acids that cannot be endogenously synthesized are expected 
to yield higher correlations. They include polyunsaturated fatty acids (e.g., DHA and EPA), 
trans fatty acids, and odd-numbered saturated fatty acids (Willett, 1998).  
a) Polyunsaturated Fatty Acids 
 Previous studies comparing serum fatty acids and fatty acid intakes focused on 
polyunsaturated fatty acids (e.g., DHA and EPA) (Ma et al., 1995; Andersen et al., 1996; 
Hjartaker et al., 1997; Andersen et al., 1999; Hodge et al., 2007). Among the 
polyunsaturated fatty acids, DHA and EPA generally have the highest correlations. Their 
correlations range from 0.29 to 0.78 and from 0.21 to 0.51, respectively. The correlations for 
DHA and EPA are generally good because they derive from a specific dietary source – fish 
or fish oil supplements – and are not endogenously synthesized in large amounts. Cold 
water oily fish (salmon, mackerel, and herring) have the most EPA and DHA (Kris-Etherton 
et al., 2002). A fatty acid precursor can be converted to DHA and EPA, but the extent of this 
conversion is modest (Kris-Etherton et al., 2002). Serum DPA, the intermediate fatty acid 
between EPA and DHA, and linoleic acids also have moderate correlations with intake. 
b) Trans Fatty Acids 
 The three major trans fatty acids are: palmitelaidic acid (16:1t), 18:1t, and linolaidic acid 
(18:2tt). The dietary sources of these fatty acids are industrially manufactured partially 
hydrogenated oils (18:1t and 18:2tt) or meat and dairy products (16:1t and 18:1t).  Linelaidic 
acid may be more atherogenic than 18:1t or palmitelaidic acids (Baylin et al., 2003). In 
contrast to polyunsaturated fatty acids, which have been well-characterized, only one study 
has examined correlations for serum trans fatty acids (Sun et al., 2007). This study reported 
moderate correlations for serum 18:1t and palmitelaidic acids, 0.29 and 0.27, respectively, 
and a lower correlation for linelaidic acid, r=0.19.  
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c) Odd-numbered Saturated Fatty Acids 
 The dietary source of odd-numbered saturated fatty acids is dairy fat. These serum fatty 
acids cannot be endogenously synthesized and are therefore hypothesized to have a higher 
correlation with fatty acid intake. However, with the exception of two studies, the correlations 
for odd-numbered saturated fatty acids have been uniformly low. Wolk and colleagues 
reported that the correlations between intake of dairy fat assessed by food records and 
dietary recalls for adipose tissue and serum 15:0 were 0.64 and 0.45, respectively (Wolk et 
al., 2001). Kroger and colleagues reported that the correlations for red blood cell 15:0 and 
17:0 were 0.32 and 0.28, respectively (Kroger et al., 2011). Another study of adipose tissue 
fatty acids reported low correlations for both 15:0 and 17:0 fatty acids (Baylin et al., 2002). 
The authors attributed these low correlations to their nutrient database, which did not 
include complete data on these two fatty acids. However, authors did report a moderate 
correlation between dairy fat intake and adipose 15:0 and 17:0 (r=0.31 and 0.31, 
respectively). 
 Aim 1 of this dissertation addressed the lack of studies examining serum trans fatty acid 
correlations with fatty acid intakes and lack of correlation studies among postmenopausal 
women. To determine the serum fatty acids that correlate the best with intake, we have 
conducted a cross-sectional study to examine the correlations between individual serum 
fatty acids – including trans fatty acids – and (1) individual fatty acid intakes, (2) fatty acid 
intake groups, and (3) food groups rich in fat derived from a FFQ among a cohort of 
postmenopausal women. 
C. Individual fatty acids 
 Individual fatty acid intakes, even those of the same type, are known to have different 
effects on the development of cardiovascular disease (Hu et al., 2001). However, few 
studies have examined individual fatty acid intakes and their role in the development of 
ischemic stroke. The nutrient information derived from participant reported measures used in 
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studies of dietary fat intake tend to be highly correlated. This makes distinguishing the 
associations between individual fatty acids and ischemic stroke difficult. Tissue biomarkers 
of fatty acid intake provide a less correlated measure so that individual fatty acids can be 
examined.  
1. Trans fatty acids 
 No studies have examined the association between individual serum trans fatty acids 
and ischemic stroke. There is evidence that trans isomers 18:1t and 18:2tt have a stronger 
effect on cardiovascular disease than 16:1t (Mozaffarian et al., 2009). The risk of CHD death 
and nonfatal myocardial infarction were consistently associated with higher concentrations 
of biomarker 18:1t and 18:2tt fatty acids. These associations were less consistent for 16:1t.  
2. Saturated fatty acids 
 Individual serum saturated fatty acids are of interest because they have heterogeneous 
effects on serum cholesterol. Compared with the oleic monounsaturated fatty acid, myristic 
and palmitic acids tend to increase serum total and LDL cholesterol concentrations, whereas 
stearic acid does not have a cholesterol-raising effect (Hu et al., 2001). These associations 
were reflected in one case-control study of serum fatty acids and ischemic stroke among 
Japanese (Iso et al., 2002). In this study, in unadjusted analyses, serum myristic and 
palmitic acids were positively associated with ischemic stroke, while no significant 
association was found for stearic acid. Despite the different associations found, investigators 
grouped myristic, palmitic, and stearic acids together in subsequent analyses that adjust for 
potential confounders. 
 Few ischemic stroke studies have examined serum 15:0 and 17:0 saturated fatty acids 
in relation to ischemic stroke. These serum fatty acids are present in small amounts and are 
thought to be markers of milk fat intake, since these fatty acids cannot be endogenously 
synthesized. A case-control study of stroke in Northern Sweden reported that that serum 
15:0 and 17:0 were inversely associated with total stroke (ischemic + 
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hemorrhagic) (Warensjo et al., 2009). These associations have not been confirmed in 
studies examining ischemic stroke specifically. 
3. Polyunsaturated fatty acids 
 Most telling of the importance of examining fatty acids individually are the associations 
between DHA and EPA intake versus total polyunsaturated fatty acids and ischemic stroke. 
Studies that examined total polyunsaturated fat intake reported null associations with 
ischemic stroke (Gillman et al., 1997; Seino et al., 1997; He et al., 2003; Sauvaget et al., 
2004), while studies that examined DHA and EPA specifically reported significant inverse 
associations (Iso, Rexrode, et al., 2001; He et al., 2002). These results could be due to other 
fatty acids diluting the inverse association between DHA and EPA intake and ischemic 
stroke. The implication for future studies is that even longitudinal studies that measure fat 
intake through self-report should examine the associations between individual fatty acid 
intakes and disease, not fat intake groups. Combining fatty acid into groups, in particular 
combining n3 and n6 polyunsaturated fatty acids, could mask any potential association of 
individual fatty acids, depending on their relative contribution. However, few studies of fatty 
acid intakes were able to examine fatty acids individually. 
D. Ischemic Stroke Subtypes 
 Previous studies of dietary fat intake and ischemic stroke were inconsistent with CHD 
studies, despite the fact that CHD and ischemic stroke share some major risk factors and 
are both thought to be atherosclerotic disorders. One possible explanation of the 
inconsistent findings is that ischemic stroke is a heterogeneous condition. Atherosclerosis 
may be a more proximate cause of some ischemic stroke subtypes, but not others. Given 
that fatty acid intakes have a strong effect on the effect of atherosclerosis development 
through serum cholesterol, fatty acid intakes could have a stronger effect on the 
development of some ischemic stroke subtypes. To investigate this possibility, we should 
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examine the association between fatty acids and ischemic stroke subtypes, rather than 
ischemic stroke as a composite outcome. This section describes the ischemic stroke 
subtypes, including atherothrombotic (large artery), lacunar (small artery), and cardioembolic 
strokes. 
1. Classification of ischemic stroke 
 Usually strokes are classified into two groups: ischemic and hemorrhagic. The etiologies 
of these two types of stroke are entirely different. Ischemic stroke is caused by obstruction 
within a blood vessel supplying blood to the brain. Hemorrhagic stroke, on the other hand, is 
caused by bleeding into the brain when a weakened blood vessel ruptures. In the US, 
approximately 87% of strokes are ischemic (Roger et al., 2012). The focus of this 
dissertation is ischemic strokes. 
 Ischemic strokes may be further classified by their etiology, or the origin of the 
obstruction, as thrombotic or embolic. A thrombotic stroke occurs when an obstructing blood 
clot (thrombus) forms locally within an artery of the brain. Atherosclerosis is the most 
prevalent cause of thrombotic strokes occurring in the large arteries of the brain. 
Mechanisms related to hypertension are common causes of thrombotic stroke occurring in 
the small vessels of the intracerebral arterial system. Embolic strokes are the result of a 
traveling blood clot to the brain, usually from a cardiac, aortic, or arterial source. Each of 
these subtypes has distinguishing prognosis, outcomes, and treatment, emphasizing the 
need to examine ischemic stroke subtypes separately. 
 The Trial of Org 10172 in Acute Stroke Treatment (TOAST) formalized this etiologic 
classification scheme for use in clinical trials and population studies, striving for a uniformity 
in diagnoses and greater interphysician consistency (Adams et al., 1993). Ischemic strokes 
may be classified according to five TOAST categories (Table 1). 
This classification is based on a combination of clinical features and diagnostic tests to 
confirm etiology, since clinical features used to rapidly determine course of action alone are 
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often nonspecific (Madden et al., 1995). The classification showed moderate to good 
interphysician reliability, which improved with the use of standardized medical abstraction 
procedures and a computerized algorithm (Lindley et al., 1993; Madden et al., 1995; 
Goldstein et al., 2001). One limitation of the TOAST classification scheme is the large 
proportion of strokes classified as having undetermined etiology (Kolominsky-Rabas et al., 
2001; Wassertheil-Smoller et al., 2003). Advances in stroke imaging and evaluation 
diagnostics have led to an increasing proportion of stroke to be classified as “undetermined” 
(e.g. two or more causes identified). The strict TOAST guidelines improve the specificity of 
the first 3 categories, but they also limit statistical power to examine those categories. 
Another limitation is that the TOAST classification uses a history of diabetes mellitus and 
hypertension in its lacunar stroke definition (Adams et al., 1993). Some studies suggest that 
blood pressure causes lacunar stroke more than other ischemic stroke subtypes, but this 
may be due to the TOAST classification. One study using “risk factor-free classification” 
found that the population attributable fraction for hypertension was approximately 35% for all 
ischemic stroke subtypes (Ohira et al., 2006). This study advocated the use of a “risk factor-
free classification” to avoid classification bias. Still, the TOAST classification is the best 
available for etiologic studies of ischemic stroke (Wassertheil-Smoller et al., 2003). 
2. Atherothrombotic stroke (large artery) 
 Atherosclerotic strokes are occlusions that occur in the extracranial (common and 
internal carotids and vertebral) and intracranial (Circle of Willis and proximal branches) 
arteries. The neurologic deficit that occurs with this type of stroke often fluctuates and may 
occur over a short or long period of time. Compared with patients with lacunar strokes, these 
large-artery infarcts are more likely to develop over a long period of time. Symptoms of a 
blocked left or right internal carotid arteries or middle cerebral arteries, which supply blood to 
the opposite side of the brain, include trouble communicating, or right or left body weakness, 
numbness, or loss of vision, respectively. Blockage of the left or right vertebral arteries or 
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basilar arteries, which supply blood to the brainstem and the back of the brain causes 
weakness or numbness on either side of the body, vertigo, nausea, vomiting, unsteadiness, 
or coma. Atherosclerotic infarcts block arteries that supply blood to large portions of the 
brain and may result in a large amount of brain damage. Angiography, a relatively invasive 
procedure with inherent risks, is the gold standard for diagnosing atherothrombotic 
stroke (Madden et al., 1995). Treatment options for atherosclerotic strokes include 
antiplatelet therapy, revascularization, and anticoagulation. 
 In the US, atherothrombotic strokes occur less frequently than lacunar or cardioembolic 
stroke making these types of strokes particularly difficult to accumulate in epidemiologic 
studies (Figure 3). Still, intracranial stenosis causes approximately 50,000 ischemic strokes 
each year. Approximately 5% to 10% of ischemic strokes among whites are caused by 
atherothrombotic stroke, a proportion that is higher among blacks (14%), Hispanics (20%), 
Japanese (21%), and South Asians (27%) (R. L. Sacco et al., 1995; Syed et al., 2003; Turin 
et al., 2010). These racial differences are due to the proportions of intracranial, rather than 
extracranial, atherothrombotic strokes. Of all the ischemic strokes in the Northern Manhattan 
Stroke Study, 8% and 8% (52 and 50 of 661 ischemic strokes, respectively) were caused by 
intracranial and extracranial atherothrombotic strokes, respectively. In combination, this 
study had a higher proportion of atherothrombotic stroke than US whites because of the 
racial diversity among study participants (Rincon et al., 2009). The higher prevalence of 
diabetes and hypercholesterolemia among blacks and Hispanics accounted for much of the 
increased frequency of intracranial atherosclerotic stroke (R. L. Sacco et al., 1995; Ohira et 
al., 2006). Individuals with both type I and type II diabetes are associated with substantially 
increased risks of thrombotic stroke, including atherothrombotic stroke (Janghorbani et al., 
2007).  
 Kuller and Reisler developed the hypothesis that serum cholesterol played a larger role 
in the development of atherothrombotic stroke than other subtypes of ischemic stroke. 
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These investigators examined the incidence of ischemic stroke subtypes in populations with 
high and low serum cholesterol levels (Kuller & Reisler, 1971). They found the ischemic 
strokes that occurred among populations with high serum cholesterol levels were mainly 
intracranial and extracranial. Intracranial and extracranial ischemic strokes define 
atherothrombotic stroke. Based on this observation, high serum cholesterol levels seemed 
to be related to atherothrombotic stroke, but not other subtypes of ischemic stroke. Given 
the strong effect of fatty acid intakes on serum cholesterol, we hypothesized that fatty acid 
intakes would have an effect on atherothrombotic stroke, but not other subtypes of ischemic 
stroke. The Honolulu Heart Program reported evidence for the effect of dietary fat on 
subtypes of ischemic stroke (D. M. Reed, 1990). In 198 men, the levels of atherosclerosis 
were greater in the large arteries in the Circle of Willis than in the small arteries in those who 
reported low intake of fat and animal protein. These studies suggest that dietary fat intake 
and atherosclerosis may only be involved in atherothrombotic stroke. However, there have 
been no confirmatory reports on the associations of types of fat (both dietary or fatty acid 
biomarkers) and types of ischemic stroke. Studies that have attempted to examine the 
associations between fatty acids and atherothrombotic stroke have been limited by low 
statistical power (Iso et al., 2002; Yaemsiri et al., 2012 [in press]).  
3. Lacunar stroke (Small vessel) 
 Lacunar infarcts are occlusions that are 0.2-15mm in diameter occurring in the arteries 
that branch off from large cerebral arteries and supply blood to deep in the brain. Occlusion 
of these smaller arteries is most often caused by lipohyalinosis (small vessel disease) or 
microatheroma (atherosclerosis), both consequences of systemic hypertension (Fisher, 
1982). A lacunar infarct can cause any of the symptoms of ischemic stroke, notably 
weakness or numbness on one side of the body. Compared with non-lacunar strokes, small 
artery infarcts have a better short-term (<1yr) prognosis (Bamford et al., 1987; S. E. Sacco 
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et al., 1991; The Publications Committee for the Trial of ORG 10172 in Acute Stroke 
Treatment (TOAST) Investigators, 1998). 
 In the US, the annual incidence of lacunar infarcts is 25/100,000 overall and 52/100,000 
among blacks (Petty et al., 1999; Woo et al., 1999). Lacunar stroke incidence is higher 
among US blacks than whites, probably due to having a higher prevalence of hypertension 
and diabetes. Lacunar infarcts make up 16-22% of all ischemic strokes in the US, but 
comprise a much larger proportion of all ischemic strokes among the Japanese; 
approximately 80% of ischemic strokes in Japanese are lacunar (D. Reed et al., 1994; Iso et 
al., 2002). Over the last 40 years, the incidence of lacunar stroke, but not other types of 
ischemic stroke, has steadily declined in Japan probably due to better hypertension control 
and decrease of other risk factors, namely diabetes and smoking (Kubo et al., 2006). In fact, 
treatment of systolic hypertension reduced risk of lacunar and possibly embolic strokes, but 
not atherosclerotic strokes (Perry et al., 2000). Results of this study contrast with others that 
suggest lacunar infarcts are not more likely to occur from hypertension (Lodder et al., 1990; 
Petty et al., 1999).  
 Serum fatty acids and fatty acid intakes have been shown to be associated with lacunar 
stroke. Investigators of a case control study of serum fatty acids and ischemic stroke 
subtypes reported a positive association between serum saturated fatty acids and ischemic 
stroke, and an inverse association for serum linoleic acid (Iso et al., 2002). These 
associations were driven by lacunar stroke, this subtype making up 95 of the 122 ischemic 
strokes. A more recent study of dietary fat intake and ischemic stroke reported a positive 
association between trans fat intake and ischemic stroke that was consistent for lacunar 
stroke, but not other subtypes of ischemic stroke (Yaemsiri et al., 2012 [in press]). 
Polyunsaturated fatty acids may be associated with lower incidence of lacunar stroke 
through their antihypertensive effect (Geleijnse et al., 2002). Trans fatty acids are not 
thought to have an effect on blood pressure, but may raise the incidence of lacunar stroke 
  24
through inflammatory mechanisms (Mozaffarian et al., 2009). However, we hypothesize that 
the main mechanism by which fatty acid intakes increase risk of ischemic stroke is through 
serum cholesterol’s effect on increasing risk of atherothrombotic stroke. 
4. Cardioembolic stroke 
 Cardioembolic stroke is caused by a blood clot (embolism) that forms in the heart, 
travels through the bloodstream, and blocks an artery supplying blood to the brain. Common 
sources of embolism include arrhythmias, especially atrial fibrillation, valve disorder, and 
heart failure. These diseases may cause normally flowing blood to pool, increasing the 
possibility of clot formation. Atrial fibrillation may develop following cardiac surgery, 
increasing concern for cardioembolic stroke. Compared with thrombotic strokes, the 
neurologic deficit associated with cardioembolic stroke is large. Onset of the deficit, as well 
as recovery after clearing the embolus, occurs quickly. 
 Treatment for cardioembolic stroke differs from other ischemic strokes in that treatment 
of both the local infarct and the cardiac source of the thrombus are important to prevent 
recurrence. Further distinguishing this subtype of ischemic stroke, long-term prevention of 
cardioembolic stroke includes anticoagulants therapy (warfarin); antiplatelets alone are not 
sufficient to prevent recurrence (R. L. Sacco et al., 2006). To prevent recurrence with proper 
treatment, all patients with possible stroke must undergo a thorough cardiac evaluation. 
 Cardioembolic stroke accounts for approximately 20% of all ischemic strokes (R. L. 
Sacco et al., 2006). They occur more frequently among US whites, than US blacks or 
Hispanics (R. L. Sacco et al., 1995), but these differences are attributable to prevalent risk 
factors, such as age, adiposity, systolic blood pressure, and HDL cholesterol (Ohira et al., 
2006). The most important risk factor for cardioembolic stroke is atrial fibrillation. Atrial 
fibrillation increases risk of stroke five-fold. One in four strokes among the elderly are 
attributable to atrial fibrillation (Roger et al., 2012). In addition, younger patients with heart 
disease are more likely to have cardioembolic stroke compared with other ischemic strokes. 
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Cardiac surgery is also a major risk factor for cardioembolic strokes. Adverse cerebral 
outcomes occur in 6.1% of patients who undergo a coronary bypass surgery (Roach et al., 
1996). Approximately half of patients who experience a cerebral outcome have focal 
neurologic damage and the other half experience a deterioration of intellectual function or 
seizures. 
  Fatty acids may play a distal role in cardioembolic strokes through their effect on serum 
cholesterol, the development of atherosclerosis, and coronary heart disease. However, their 
effect on atherothrombotic stroke, or even lacunar stroke, should be more apparent than 
their effect on cardioembolic stroke. 
 26
 
 
 
V. METHODS 
 The aims of this dissertation were (1) to examine the correlations between serum fatty 
acids and fatty acid intakes and (2) to examine the associations between individual fatty 
acids and ischemic stroke and its subtypes. We increased statistical power to meet these 
objectives by using data from the WHI-OS, a large cohort of postmenopausal women. We 
will address the first aim using a cross-sectional study design and calculating Spearman 
rank correlation coefficients between serum fatty acids and fatty acid intakes. We will 
address the second aim using a matched case-control study design. Given this study 
design, we will use conditional logistic regression, conditioning on the matched factors, to 
examine the associations between fatty acids and ischemic stroke. This dissertation involves 
the analysis of extant data. Data from this dissertation were derived from two Women’s 
Health Initiative Observational Study ancillary studies: (1) Stroke risk factors and molecular 
markers in postmenopausal women (AS126, PI: Dr. Sylvia Wassertheil-Smoller) and (2) 
Serum fatty acids and incidence of ischemic stroke in women (AS187, PI: Dr. Ka He). This 
section provides a description of the data and the analytic procedures.  
A. The Women’s Health Initiative Observational Study 
 The WHI-OS is a long-term prospective cohort study to identify and assess the impact of 
biological, lifestyle, biochemical, and genetic factors on the risk of heart disease, cancer, 
osteoporosis, and other major health events. Between 1993 and 1998, the WHI-OS 
recruited women age 50 to 79 years from areas surrounding 40 clinical centers in 24 states 
and the District of Columbia and enrolled 93,676 women (Hays et al., 2003). The cohort is 
closed, so no additional recruitment or enrollment  occurred since baseline. The design of 
the WHI-OS has been described previously (Prentice et al., 1998).  
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The baseline characteristics of the participants have been published (Langer et al., 
2003). The WHI-OS cohort is somewhat healthier than a probability sample of US women 
age 55-74 in the NHANES III cohort (1988-1994). Among women aged 50 to 79 in the 
NHANES III, 48% were hypertensive, 7% reported a history of physician-diagnosed heart 
attack, and 5% reported a physician-diagnosed stroke. The prevalence of these conditions 
in the WHI-OS at baseline was 33.5%, 2.5%, and 1.5%, respectively. Table 2 compares 
other characteristics of WHI-OS women to that of US women ages 50-79 from the NHANES 
1999-2000 (the NHANES was not conducted during WHI enrollment between 1993 and 
1998). Compared with US women, WHI women were more likely to have higher levels of 
formal education and have higher household incomes. WHI women were less likely to be 
obese or be a current smoker. While the WHI cohort is not representative of 
postmenopausal US women, much less adults worldwide in the sense of a probability 
sample, its nonrepresentativeness is assumed to be unrelated to the biologic mechanism 
linking serum fatty acids and the development of ischemic stroke. In fact, limiting the study 
population to postmenopausal US women without safety or retention concerns maximizes 
the internal validity and aids generalizability to unstudied groups (Rothman et al., 2008). 
B. Case identification and classification 
 Of the 93,676 participants in the WHI-OS, we excluded 9,831 women for not meeting 
study eligibility criteria (having no previous history of myocardial infarction or stroke and 
adequate blood sample available for the biomarker assays) and 627 women with a locally 
adjudicated ischemic stroke that was not confirmed by central adjudication (Wassertheil-
Smoller et al., 2008). These exclusions left a remaining cohort of 82,591 women from 
among whom the stroke case and control subjects were selected.   
Incident ischemic strokes during the follow-up period were identified through self-report 
during annual medical history updates (annual response rate 94%) (Curb et al., 2003). 
Using additional details from medical charts, brain imaging, or death certificates, the 
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potential outcomes were subject to local adjudication by physicians, then central 
adjudication by trained neurologists, according to standard criteria. Over 95% of participant-
reported stroke cases were classified based on brain imaging (Chen et al., 2008). There 
were 972 confirmed incident ischemic stroke cases between 1993 and 2003. 
Central adjudicators further classified ischemic strokes by subtypes according to the 
Trial of ORG 10172 Acute Stroke Trial (TOAST) Classification, based on the presumed 
underlying stroke etiology (Table 1) (Goldstein et al., 2001). The TOAST classification 
system includes five categories: atherothrombotic stroke, lacunar stroke, cardioembolic 
stroke, stroke of other determined etiology, and stroke of undetermined etiology. The 
classification is based on clinical features, brain imaging (CT/MRI), cardiac imaging 
(echocardiography, etc.), duplex imaging of extracranial arteries, arteriography, and 
laboratory assessments for a pro-thrombotic state. Probable and possible subtypes 
determinations were combined in this report. Transient ischemic attack, hemorrhagic stroke, 
strokes not requiring hospitalization, and strokes not confirmed by central adjudication were 
not included as a stroke outcome. 
C. Control selection 
 Controls were sampled from the risk set when ischemic stroke events occurred during 
the follow-up period (incidence density matching) and matched 1:1 to case subjects on age 
at screening (±2 years), race/ethnicity (white, black, Hispanic, Asian, American Indian, or 
other/unspecified), date of study enrollment (±3 months), and follow-up time (control follow-
up time greater than case follow-up time).  
  29
D. Baseline data collection 
Baseline data were collected by trained and certified clinical center staff using self-
administered forms and interviews and making clinical measurements (Table 3) (Anderson 
et al., 2003).  
1. Blood specimen and serum fatty acid assessment 
 Fasting blood samples were collected from women at study baseline by clinic staff 
members following a standardized protocol for venipuncture (Anderson et al., 2003). 
Samples were centrifuged, separated by layers, frozen onsite at -70°C, and shipped to the 
central WHI repository for long-term storage. Blood samples from the selected cases and 
controls were sent to Dr. Rhobert Evans’ laboratory at the University of Pittsburgh for serum 
fatty acid assessment. 
 Fatty acids (Table 4) were extracted according to the general technique of Bligh and 
Dyer (Bligh & Dyer, 1959) using 1, 2-dinonadecanoyl-sn-glycero-3-phosphocholine (Avanti 
Polar Lipids, Inc. Alabaster, AL) (50 µg of 19:0) as an internal standard. The lipid extracts 
were resuspended in 1.5 ml 14% boron trifluoride methanol and derivatized according to the 
procedure of Morrison and Smith (Morrison & Smith, 1964). The extracts were analyzed by 
capillary GC:column (SP-2380, 105 m x 53 mm ID, 0.20 um film thickness). The gas 
chromatograph was a Perkin Elmer Clarus 500 equipped with a flame ionization detector. 
Operating conditions: the oven temperature was 140°C for 35 min, then ramped at 8°C/min 
to 220°C, and held for 12 min. Injector and detecto r temperatures were both at 260°C and 
helium, the carrier gas, was at 15 psi. Identification of components was by comparison of 
retention times with those of authentic standards (Sigma). Duplicate samples and control 
pools were analyzed with each batch of samples.  
 Lipoprotein profiles were assayed at Liposcience using nuclear magnetic resonance. 
Low-density lipoprotein (LDL) cholesterol was calculated from high-density lipoprotein (HDL) 
cholesterol, total cholesterol, and triglyceride concentrations among women who had a 
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triglyceride value <400 mg/dL using the Friedewald equation (National Cholesterol 
Education Program Expert Panel on Detection, 2002). LDL cholesterol values were set to 
missing for those women whose triglyceride value was >400 mg/dL (n=35) or who were 
missing HDL cholesterol, total cholesterol, or triglyceride values (n=7).  
 Fasting glucose was assayed by the hexokinase method (Anderson et al., 2003). 
2. Demographics 
Participants reported their age, race, level of formal education, and household income. 
Participants could report their race/ethnicity as American Indian or Alaskan Native, Asian or 
Pacific Islander, Black or African-American, Hispanic/Latino, White (not of Hispanic origin), 
or other. Because of the relatively low number of non-white participants, we dichotomized 
race/ethnicity as white and non-white for Aim 1. All six categories of race/ethnicity were used 
as matching factors in Aim 2. Levels of formal education were collapsed into three 
categories (completed high school or obtained General Equivalency Diploma or less, some 
college or training, and college graduate). Levels of household income were collapsed into 
three categories, as well (<$35,000, $35,000 to $74,999, and ≥$75,000).  
3. Medical history 
 Participants reported their history of treatment for diabetes, atrial fibrillation, angina, and 
revascularization. Using additional information from blood biomarkers, diabetes (yes, no) 
was defined as being on treatment for diabetes by self-report or having a fasting glucose 
level ≥126 mg/dL.  
4. Physical activity, alcohol consumption, smoking 
 Participants reported their recreational physical activity, alcohol intake, and smoking 
status. Recreational physical activity was assessed by asking about the frequencies and 
duration of walking at various intensities and other types of recreational physical activity 
classified by intensity (strenuous, moderate, or light). These data were summarized into total 
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metabolic equivalent task (MET)-hours per week and categorized by episodes per week of 
moderate or strenuous activity of 20 minutes or more duration (as defined by a metabolic 
equivalent score of at least 4.0) (Ainsworth et al., 1993). Participants were queried about 
their past and current alcohol consumption and were categorized as past drinker, current 
drinker, <7 drinks/wk, or ≥7 drinks/wk. Smoking status was dichotomized as current smoker 
(yes, no).  
5. Food frequency questionnaire 
The WHI used a self-administered food frequency questionnaire (FFQ) to assess 
diet (Patterson et al., 1999). The FFQ asked about usual frequency of intake and portion 
size for 122 foods and food groups over the previous 3-month period, including questions 
about fats in meat and dairy and reduced-fat foods. It also included 19 adjustment questions 
that permitted a more refined analysis of fat intake by asking about food preparation 
practices and types of added fats. In addition, 4 summary questions asked about usual 
intake of fruits, vegetables, and fats added to foods and used in cooking. Participants 
received a sheet with portion size pictures to standardize portion size. The nutrient database 
was derived from the University of Minnesota Nutrition Coding Center nutrient database 
(2005 version, Nutrition Coordinating Center, Minneapolis, MN). We compared food groups 
that are rich in fat and nutrient variables derived from the WHI FFQ with serum fatty acid 
concentrations for Aim 1 (Table 5).  
The measurement properties of the WHI FFQ were evaluated in a sub-sample of the 
WHI and were found to be similar to other FFQs in studies of older women (Patterson et al., 
1999). The Pearson correlation coefficient between the FFQ and 8 days of dietary recalls 
and food records were 0.64 for total fat, 0.63 for saturated fat, 0.64 for monounsaturated fat, 
and 0.54 for polyunsaturated fat. The correlation coefficient for trans fat was not reported in 
the evaluation study. However, in the WHI Dietary Modification Clinical Trial, a trend was 
observed toward CHD reduction among the intervention group who reached the lowest 
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levels of trans fat and saturated fat intakes, as measured by the WHI FFQ (Howard et al., 
2006). These results demonstrate that the WHI FFQ dietary trans fat intake assessment is 
appropriate and can successfully predict health endpoints including ischemic stroke by 
ranking participants according to intake. 
6. Hormone replacement therapy use 
To capture hormone use prior to WHI enrollment, an in-person interview was conducted 
with each woman to determine her entire history of postmenopausal hormone 
use (Anderson et al., 2003). We categorized women as being current, past, or never users 
of hormone replacement therapy (estrogen plus progesterone or unopposed estrogen).  
7. Current medications 
Use of medications and dietary supplements was captured directly from pill bottles that 
participants were asked to bring to the clinic. The medications were recorded by an 
interviewer and matched to a Medication Therapeutic Class. Participants who reported 
taking pills for hypertension or medication in the antihypertensive or diuretic therapeutic 
classes were classified as antihypertension medication users. Those who reported having 
high cholesterol requiring pills or taking medication in the antihyperlipidemic therapeutic 
classes were classified as cholesterol-lowering medication users. Participants who reported 
taking medications that contained aspirin as an ingredient for at least 14 days were 
classified aspirin users.  
8. Blood pressure 
Blood pressure was measured at a baseline clinic visit by certified staff using 
standardized procedures after a 5-minute seated rest. Two systolic and diastolic blood 
pressure measurements were taken with a 30-second rest in between. The average of the 
first and second systolic and diastolic blood pressure readings were averaged. Since 
systolic and diastolic blood pressures are highly correlated, only systolic blood pressure was 
used in analysis.  
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9. Height and weight 
 Certified clinic staff measured participant height, weight, and blood pressure. Height and 
weight were measured without shoes or heavy clothing and with pocket contents removed. 
Body mass index (BMI) was calculated by dividing weight in kilograms by the square of 
height in meters. Participants were categorized as having BMI <25.0, 25.0 to 29.9, or ≥ 30.0 
kg/m2.  
 Following standardized procedures, blood pressure was measured twice after a 5-
minute seated rest with a 30-second rest in between. The average of two blood pressure 
measurements was used in analysis. Hypertension was defined as self-report of 
antihypertensive medication use or systolic blood pressure ≥ 140 mm Hg or a diastolic blood 
pressure ≥ 90 mm Hg.  
E. Statistical analysis 
 All analyses were performed using SAS statistical software (version 9.2, SAS Institute 
Inc., Cary, NC, USA). 
1. Aim 1 analyses 
 The objective of aim 1 was to calculate the correlation coefficients between individual 
serum fatty acids and fatty acid intakes. In addition, we calculated the correlation coefficients 
for intakes of fatty acid groups and selected food groups rich in fat. Aim 1 analyses excluded 
women who developed ischemic stroke during follow-up and women who reported 
implausible daily energy intake (<600 or >5000 kcal), leaving 925 women in this analysis. 
Even though women with a history of myocardial infarction or stroke were excluded from 
being selected as a case or control, we further excluded women who developed ischemic 
stroke during follow-up since they may have had another condition at baseline that may 
have caused their fat intake or metabolism to be substantially different from the women who 
did not develop ischemic stroke. 
  34
We calculated Spearman, rather than Pearson, correlation coefficients to account for the 
highly skewed serum fatty acid and fatty acid intake variables. Unlike Pearson correlation 
coefficients, Spearman rank correlation coefficients do not need to be normally distributed 
since they convert the values to ranks. We considered correlations r≥0.20 with P≤0.001 to 
be statistically significant to account for multiple comparisons. P≤0.001 is more conservative 
than the Bonferroni correction for P≤0.05 for 25 comparisons. 
Our primary analysis was unadjusted, rather than adjusted or partial, correlation 
coefficients between serum fatty acids and fatty acid intakes and food groups. Since our 
objective was to estimate the correlations in this population of postmenopausal US women, 
adjustment for other variables would decrease the correlations’ relevance to this study 
population. We adjusted the correlation coefficients for age (continuous), race (white, non-
white), BMI group (<25, 25 to <30, ≥30 kg/m2), and current smoking status (no, yes) in 
secondary analyses. These variables are markers of major lifestyle factors and biological 
processes that can influence fatty acid intakes and serum fatty acid concentration. 
2. Aim 2 analyses 
The objective of Aim 2 was to examine the associations between individual serum fatty 
acids and ischemic stroke and its subtypes. Aim 2 analyses included 964 matched ischemic 
stroke case and control pairs with sufficient serum samples.  
To account for the matched design, we used conditional logistic regression to calculate 
odds ratios (OR) and 95% confidence intervals (CI) for ischemic stroke and its subtypes, 
conditioning on matching factors in all models. We estimated ORs and 95% CIs comparing 
the odds of ischemic stroke among women in the higher quintiles of serum fatty acids with 
the odds of ischemic stroke among women in the first quintile. Linear trend tests were 
performed by assigning the median value of the quintile of the fatty acid to each category 
and entering this variable into the model as a continuous variable. Since trends were 
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generally linear, unadjusted ORs were calculated per 1-standard deviation (SD) increment in 
each serum fatty acid (Model 1, Table 6). 
Potential confounders were identified by determining which variables were related both 
to serum fatty acids and to ischemic stroke (Figure 4). In a matched case-control study 
where the inclusion of a case-control pair depends on both having complete covariate data, 
we were careful to add only variables that are justified and necessary to maximize statistical 
power. Cases and controls were already matched on age and race/ethnicity. Therefore, we 
considered other comorbidities and lifestyle factors that would affect serum fatty acid 
concentrations and ischemic stroke incidence: BMI, smoking status, diabetes, and aspirin 
use. The model controlling for these variables was our primary model (Model 2, Table 6). 
These variables were associated with ischemic stroke in our study and are markers of 
comorbidities and lifestyle that could affect serum fatty acid concentrations and ischemic 
stroke incidence. We additionally adjusted for two potential mediators, blood pressure and 
serum cholesterol, in secondary analyses (Models 3 and 4, Table 6). Associations with two-
sided P ≤ 0.001 was considered significant to account for multiple comparisons. This is a 
more conservative P than the Bonferroni correction of P ≤ 0.05 for 25 comparisons.  
F. IRB/Human subjects 
Approval for this project was obtained through the Institutional Review Board of the 
University of North Carolina Gillings School of Global Public Health on 6/29/2011 for Aim 1 
and 7/8/2008 for Aim 2. No additional contact was made with study participants, as all 
analyses were of secondary data. The WHI study coordinators at each clinic site obtained 
approval for data collection.  
G. WHI Publications and Presentations (P&P) Committee 
 The WHI P&P Committee approved the paper proposals related to Aims 1 and 2 of this 
dissertation.   
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VI. Correlations Between Serum Fatty Acids and Fatty Acid  
Intakes Among Postmenopausal Women 
This manuscript presents the results and discusses the implications of Aim 1. This 
manuscript addresses the correlations between individual serum fatty acids with (1) fatty 
acid intakes, (2) fatty acid groups, and (3) food groups. We examined correlations for 
individual trans fatty acids, which few studies have examined previously.  
A. SUMMARY 
Background: Serum fatty acid concentrations have been proposed as a useful method 
of indirectly measuring fatty acid intake. It is unclear which serum fatty acids are valid 
biomarkers of fatty acid intake among postmenopausal US women. 
Objective: We examined the correlations between serum fatty acids and intakes of fatty 
acids and food groups rich in fat among postmenopausal women in the Women’s Health 
Initiative Observational Study. 
Design: Participants were 925 women aged 50 to 79 years. Serum fatty acids were 
assessed using gas chromatography from a fasting serum sample. Intakes of fatty acids and 
food groups were derived from a 122-item food frequency questionnaire. Spearman 
correlation coefficients and measures of agreement were calculated.  
Results: The major components of total serum fatty acids were linoleic (18:2n6, 27%), 
palmitic (16:0, 24%), oleic (18:1n9, 18%), stearic (18:0, 9%), and arachidonic (20:4n6, 8%) 
acids. Serum docosahexaenoic acid (DHA, 22:6n3, r=0.53), eicosapentaenoic acid (EPA, 
20:5n3, r=0.42), and 18:1t (r=0.39) had the strongest correlations with corresponding 
intakes. There was fair agreement between quintiles of serum and intake for DHA, EPA, and 
18:1t (weighted kappa= 0.35, 0.26, and 0.25, respectively). Serum DHA and EPA were 
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correlated with fish intake (r=0.39 and 0.35, respectively). Serum 18:1t was correlated with 
intakes of added fats, butter, and pastries (r=0.22, 0.26, and 0.30, respectively).  
Conclusions: Serum DHA, EPA, and 18:1t concentrations are suitable biomarkers of 
their corresponding fatty acid intakes as assessed by an FFQ in this cohort of 
postmenopausal US women.  
B. INTRODUCTION  
 Fatty acid intake and metabolism play important roles in the development of 
cardiovascular disease (Hu et al., 2001). One of the challenges in studying fatty acid intake 
is measurement (Arab, 2003). There are two primary methods of measuring fatty acid 
intake: directly through food chemistry or participant report (e.g., food frequency 
questionnaire [FFQ]) and indirectly through the use of a biological marker (Willett, 1998).  
 Most large-scale observational studies use the FFQ, a tool that aims to measure usual 
food intake in relation to chronic disease. Its usefulness is limited by participants who may 
be reluctant or unable to report food intake accurately (Willett, 1998). Further, nutritional 
databases that convert foods to fatty acids may not be updated to reflect the continuously 
changing fatty acid content of food items. Therefore, measurement of fatty acid 
concentrations in tissues (serum, adipose, and red blood cells) have been proposed as an 
objective method of indirectly measuring intake of foods rich in fat and fatty acid intake. 
Whereas foods and fatty acids derived from the FFQ reflect intake but not metabolic 
processes, serum fatty acids reflect intake after absorption, transport, uptake, metabolism, 
and excretion of dietary fatty acids and endogenous synthesis of fatty acids (Arab & Akbar, 
2002). 
 Given these differences between serum fatty acids and intake, comparisons conducted 
even within the same population are not expected to yield high correlations. However, fatty 
acids from diet that cannot be endogenously synthesized and do not undergo significant 
changes upon ingestion are expected to yield higher correlations with intake than other fatty 
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acids (Willett, 1998). These fatty acids include n3 polyunsaturated fatty acids, trans fatty 
acids, and odd-numbered fatty acids. While previous studies comparing fatty acid 
biomarkers have focused on n3 polyunsaturated fatty acids (e.g., DHA and EPA) (Ma et al., 
1995; Andersen et al., 1996; Hjartaker et al., 1997; Andersen et al., 1999; Hodge et al., 
2007; Sun et al., 2007; Patel et al., 2010), few studies have examined correlations for serum 
trans (Sun et al., 2007) or odd-numbered fatty acids. These three classes of fatty acids are 
also of interest because of their effects on a host of issues that affect the health of older 
women: ischemic stroke, osteoporosis, cognition, cancer, and autoimmune disease. 
However, few studies have examined the correlations among postmenopausal 
women (London et al., 1991; Sun et al., 2007).  
 To determine the serum fatty acids that best correlate with intake among 
postmenopausal women, we have conducted a cross-sectional study to examine the 
correlations between individual serum fatty acids and FFQ-derived i) individual fatty acid 
intakes, ii) fatty acid intake groups, and iii) food groups rich in fat.  
C. SUBJECTS AND METHODS 
1. Study Population 
 Study participants were the control participants of a case-control study nested within the 
Women’s Health Initiative Observational Study (WHI-OS). The WHI-OS is a long-term 
prospective cohort study to identify and to assess the impact of biological, lifestyle, 
biochemical, and genetic factors on the risk of heart disease, cancer, osteoporosis, and 
other major health events. Between 1993 and 1998, the WHI-OS recruited women age 50 to 
79 years from areas surrounding 40 clinical centers in 24 states and the District of Columbia 
and enrolled over 90,000 postmenopausal women. The design of the WHI-OS has been 
described previously ("Design of the Women's Health Initiative clinical trial and observational 
study. The Women's Health Initiative Study Group," 1998). 
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 The present analysis used controls from a nested case-control study of ischemic stroke. 
Controls were matched to 972 ischemic stroke cases based on age and 
race/ethnicity (Wassertheil-Smoller et al., 2008). We excluded controls whose blood quantity 
was not sufficient to analyze fatty acid content (n=4) or reported implausible daily energy 
intake (<600 or >5000 kcal, n=43), leaving 925 women in this analysis. 
2. Data collection 
 Participants completed sociodemographic and lifestyle questionnaires during baseline 
visits (Anderson et al., 2003). Anthropometric measurements were measured by certified 
clinic staff. Height and weight were measured without shoes or heavy clothing and pocket 
contents removed. Body mass index (BMI) was calculated by dividing weight in kilograms by 
the square of height in meters (National Cholesterol Education Program Expert Panel on 
Detection, 2002). Blood pressure was measured using standardized procedures after a 5-
minute seated rest. The average of two blood pressure measurements taken with a 30-
second rest in between was used in the analysis. Hypertension was defined as having a 
systolic or diastolic blood pressure equal to or greater than 140 and 90 mm Hg, respectively, 
or report of use of antihypertensive medication (National Cholesterol Education Program 
Expert Panel on Detection, 2002). 
 Fasting blood samples were collected from women at study baseline by clinic staff 
members following a standardized protocol for venipuncture (Anderson et al., 2003). 
Samples were centrifuged, separated by layers, frozen onsite at -70°C, and shipped to the 
central WHI repository for long-term storage. 
3. Serum fatty acid analysis 
 Fatty acids were extracted according to the general technique of Bligh and Dyer (Bligh & 
Dyer, 1959) using 1, 2-dinonadecanoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids, 
Inc. Alabaster, AL) (50 µg of 19:0) as an internal standard. The lipid extracts were 
resuspended in 1.5 ml 14% boron trifluoride methanol and derivatized according to the 
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procedure of Morrison and Smith (Morrison & Smith, 1964). The extracts were analyzed by 
capillary GC:column (SP-2380, 105 m x 53 mm ID, 0.20 um film thickness). The gas 
chromatograph was a Perkin Elmer Clarus 500 equipped with a flame ionization detector. 
Operating conditions: the oven temperature was 140°C for 35 min, then ramped at 8°C/min 
to 220°C, and held for 12 min. Injector and detecto r temperatures were both at 260°C and 
helium, the carrier gas, was at 15 psi. Identification of components was by comparison of 
retention times with those of authentic standards (Sigma). Duplicate samples and control 
pools were analyzed with each batch of samples.  
4. Diet assessment 
 The WHI used a self-administered FFQ to assess diet at baseline. The FFQ asked about 
usual frequency of intake and portion size for 122 foods and food groups over the previous 
3-month period. The nutrient database was derived from the University of Minnesota 
Nutrition Coding Center nutrient database (2005 version, Nutrition Coordinating Center, 
Minneapolis, MN). The measurement properties of the WHI FFQ were evaluated against 
four 24-hour recalls and 4-day food records in a subcohort of 113 WHI 
participants (Patterson et al., 1999). The Pearson correlation coefficients were 0.64 for total 
fat, 0.63 for saturated fat, 0.64 for monounsaturated fat, and 0.54 for polyunsaturated fat. 
The correlation coefficient for trans fat was not reported in the evaluation study. 
5. Statistical analysis 
 Fatty acid intakes were calculated as a percent of total fat intake in order to be 
comparable to serum fatty acids, which were assessed as a percent of total serum fatty 
acids. The distributions of serum fatty acids and fatty acid intakes were highly skewed to the 
right. Therefore, we calculated the median as the measure of central tendency. For both 
serum fatty acids and fatty acid intakes, fatty acid groups (trans, saturated, 
monounsaturated, n3 polyunsaturated, and n6 polyunsaturated) were calculated by 
summing the concentrations of individual fatty acids in that group. 
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 To determine which serum fatty acids may be viable indirect measures of intake, 
unadjusted Spearman rank correlation coefficients were calculated between serum fatty 
acids and i) their corresponding individual fatty acid intake, ii) their corresponding fat intake 
groups, and iii) select food groups rich in fat. Partial correlations were calculated between 
serum fatty acids and fatty acid intake adjusting for age (continuous), race (white, non-
white), BMI group (<25, 25 to <30, ≥30 kg/m2), and current smoking status (no, yes). These 
variables are considered markers of major lifestyle factors and biological processes that can 
influence report of fatty acid intakes and serum fatty acid concentration. Correlations that 
were ≥ 0.20 at a P-value <0.003 (Bonferroni correlation for 16 comparisons) were 
considered statistically significant. 
 Two measures of agreement were calculated between quintiles of women defined by 
serum fatty acids and their corresponding fatty acid intake: percent agreement and weighted 
Kappa statistic. Percent agreement is the percent of women who fell into the same quintile 
on the basis of serum and intake. The weighted Kappa is a chance-corrected agreement 
rate. It is used for ordered categories and assigns less weight to agreement as categories 
are further apart. Kappa <0.00, 0.00 to 0.20, and 0.21 to 0.40 represents less than chance 
agreement, slight agreement, and fair agreement, respectively (Viera & Garrett, 2005). All 
analyses were performed using SAS statistical software (version 9.2, SAS Institute Inc., 
Cary, NC, USA). 
D. RESULTS 
1. Characteristics of the study population 
 The study population included 925 postmenopausal women age 50 to 79 years old at 
baseline (Table 7). Half of the women in the study population were age 70 to 79 years old at 
baseline. One in five of the women were obese and one in two had hypertension. Few were 
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current smokers. Women in the study population were predominately white and not of 
Hispanic origin.  
2. Composition of serum fatty acids and fatty acid intakes 
 Twenty-five individual serum fatty acids were examined (Table 4). Linoleic acid 
represented the largest proportion of serum fatty acids (27%, Figure 5). The major 
components (>5%) of serum fatty acids were linoleic acid (27%), palmitic acid (24%), oleic 
acid (18%), stearic acid (9%), and arachidonic acid (8%).  
 Sixteen individual fatty acid intakes were examined. Oleic acid represented the largest 
proportion of fatty acid intake (34%). The major components (>5%) of fatty acid intakes were 
oleic acid (34%), palmitic acid (18%), linoleic acid (18%), stearic acid (9%), and 18:1t (5%). 
3. Correlations between serum fatty acids and fatty acid intakes 
 The highest correlations between serum measures and intake were observed for DHA 
(r=0.53), EPA (r=0.42), and 18:1t (r=0.38, Figure 6). Serum saturated, monounsaturated, 
and n6 polyunsaturated fatty acids yielded low correlations with intake. There were no 
substantial differences between the unadjusted and adjusted correlation coefficients.  
4. Further investigation of serum DHA, EPA, and 18:1t 
 We examined the correlations between serum DHA, EPA, and 18:1t with their fatty acid 
intakes in various subgroups (Table 8). Correlations for serum DHA and 18:1t were lower 
among black women than white women. Also, correlations were lower among women with 
lower levels of formal education, though the differences were not statistically significant. 
However, correlations remained relatively consistent by household income. Correlations for 
serum DHA and 18:1t were lower among women with higher BMI.  
 We calculated the percent of agreement between quintiles defined by the three serum 
fatty acids and those defined by their corresponding fatty acid intake (Table 9). Fair 
agreement was observed (% agreement = 34% for DHA, 28% for EPA, and 30% for 18:1t; 
weighted Kappa statistics = 0.35 for DHA, 0.26 for EPA, and 0.25 for 18:1t). We also 
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examined the correlations between the three serum fatty acids measured at baseline with 
their fatty acid intakes measured 3 years after baseline. The correlation coefficients were 
0.47 for DHA, 0.34 for EPA, and 0.34 for 18:1t.  
5. Correlations between serum fatty acids and fat intake groups 
 The correlations for serum DHA and EPA and total n3 polyunsaturated fat intake were 
0.33 and 0.29 respectively, Table 10). Serum DHA and EPA were not correlated with total 
polyunsaturated fat intake. The correlation between serum 18:1t and trans fat intake was 
0.39. The correlation between serum pentanoic acid (15:0) was 0.24. The remaining serum 
fatty acids were not correlated with their fat intake groups. 
6. Correlations between serum fatty acids and food groups 
 Serum DHA and EPA were correlated with overall fish intake (r=0.39 and 0.35, 
respectively, Table 11). These correlations were the highest for dark fish and low-to-
moderate for white fish, tuna, and shellfish. Serum DHA and EPA were not correlated with 
fried fish. In general, serum DHA had higher correlations with fish intake than serum EPA. 
The correlation between serum DHA+EPA and overall fish intake was 0.41. Serum 18:1t 
was correlated with intake of added fat, butter, and pastries (r=0.22, 0.26, and 0.30, 
respectively). We also observed a modest correlation between serum myristic acid (14:0) 
and dairy intake (r=0.20). Correlations ≥ 0.20 were not observed for intake of red meat, 
poultry, eggs, milk, nuts, or chips. 
 We examined the correlations between DHA and EPA with fish intake in greater detail. 
The correlations between serum DHA and EPA and fish intake were lower among women 
who ate ≤ 3 medium servings of fish per month (0.12 and 0.09, respectively, n=240) and 
higher among women who ate > 3 medium servings of fish per month (0.34 and 0.29, 
respectively, n=685). Fair agreement was observed between quintiles defined by serum 
DHA and DPA and those defined by fish intake (% agreement = 28% for DHA and 26% for 
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EPA; weighted Kappa = 0.25 for DHA and 0.22 for EPA). The correlations between serum 
DHA and EPA measured at baseline with fish intake measured 3 years after baseline were 
0.35 and 0.30, respectively.  
E. DISCUSSION 
 We compared serum fatty acid concentrations with intake of individual fatty acids, fat 
groups, and food groups assessed by an FFQ. Serum DHA, EPA, and 18:1t concentrations 
were moderately correlated with their corresponding fatty acid intakes in this cohort of 
postmenopausal US women. Serum DHA and EPA were correlated with n3 polyunsaturated 
fat intake, and serum 18:1t was correlated with trans fat intake. In regards to food groups, 
serum DHA and EPA concentrations were correlated with fish intake, and serum 18:1t was 
correlated with intakes of added fat, butter, and pastries. Serum saturated, 
monounsaturated, and n6 polyunsaturated fatty acids were not correlated with fatty acid or 
food group intake. 
 As expected, we found higher correlations for fatty acids that could not be endogenously 
synthesized from carbohydrates (Willett, 1998). These fatty acids included n3 
polyunsaturated, trans, and odd-numbered fatty acids. In our study, two n3 polyunsaturated 
fatty acids, DHA and EPA, and one trans fatty acid, 18:1t, had moderate correlations. 
Consistent with the results of our study, correlations for DHA, EPA, and 18:1t were generally 
the highest of those reported in studies comparing serum/plasma fatty acids and fatty acid 
intake (Ma et al., 1995; Andersen et al., 1999; Hodge et al., 2007; Sun et al., 2007; Patel et 
al., 2010). These correlations ranged from 0.29 to 0.78 for DHA, 0.21 to 0.51 for EPA, and 
0.29 to 0.38 for 18:1t.  
 Further investigation of the correlations for DHA, EPA, and 18:1t revealed that the 
correlations varied by race, education, and body weight status. These varying correlations 
are likely the result of inaccurate reporting of intake by participants. In a study of energy 
consumption using recovery biomarkers among 544 participants in the WHI Dietary 
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Modification Trial, investigators reported that Blacks and Hispanics (vs. Caucasians) and 
those with a higher BMI were more likely to underreport total energy intake than their 
counterparts (Neuhouser et al., 2008). It is unlikely that measurement of serum fatty acids 
were systematically influenced by race, education, and BMI. Rather, the varying correlations 
were likely the result of inaccurate reporting of intake related to social desirability or ability to 
recall intake of foods by the participants. 
 We investigated the correlations between serum fatty acids and intake of foods because 
foods are more relevant to communicating dietary recommendations than individual fatty 
acids. The correlations found between DHA, EPA, and 18:1t and food groups were reflected 
by the sources of these fatty acids. The major sources of serum DHA and EPA are fish and 
fish oil (Kris-Etherton et al., 2002). The major source of 18:1t between 1993 and 1998 were 
foods made with industrially produced partially hydrogenated vegetable oil, such as butter 
and pastries (Micha et al., 2010). These findings precede the 2006 mandated labeling of 
trans fatty acids in foods and subsequent reformulation of many foods that contained trans 
fatty acids (Harnack et al., 2003). 
 Serum DHA may be a more reliable marker of fish intake than serum EPA. These 
findings are of interest because prospective studies have reported that fish consumption is 
related to lower incidence of coronary heart disease mortality and ischemic stroke (Kris-
Etherton et al., 2002; He, Song, Daviglus, Liu, Van Horn, Dyer, Goldbourt, et al., 2004; He, 
Song, Daviglus, Liu, Van Horn, Dyer, & Greenland, 2004). The specific nutrients in fish 
hypothesized to be responsible for the lower incidences were thought to be DHA and EPA 
through a variety of beneficial effects on cardiovascular risk factors (Kris-Etherton et al., 
2002). Our study and others’ report stronger correlations between fish intake and 
serum/plasma DHA than EPA, suggesting that DHA may be the more reliable marker of fish 
intake than EPA (Ma et al., 1995; Hjartaker et al., 1997; Andersen et al., 1999; Hodge et al., 
2007; Sun et al., 2007; Patel et al., 2010). Similar results were described in studies using 
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adipose tissue biomarkers (Tjonneland et al., 1993; Andersen et al., 1999; Baylin et al., 
2002). 
 Odd-numbered saturated fatty acids, 15:0 and 17:0, plus 14:0 were hypothesized to be 
markers of dairy fat intake in a study conducted by Wolk and colleagues (Wolk et al., 2001). 
We found a low-moderate correlation between serum 14:0 and dairy intake and only low 
correlations between serum 15:0 and 17:0 and dairy and milk intakes. Our study population 
had very low concentrations of serum 15:0 and 17:0, which could have resulted in the low 
correlations. Also, it is possible that the multiple 24-hour recalls and food records used by 
Wolk and colleagues were more sensitive to dairy intake than the FFQ used in the present 
study.  
 Adipose tissue and erythrocyte fatty acids are often thought to be better biomarkers of 
long-term fatty acid intake than serum based on the longer half-lives of fatty acids in these 
tissues (Sun et al., 2007). However, our results and that of others’ suggest that serum DHA, 
EPA, and 18:1t have correlations with long-term intake that are similar to or better than 
those reported for adipose tissue (Hunter et al., 1992; Tjonneland et al., 1993; Garland et 
al., 1998; Lemaitre et al., 1998; Andersen et al., 1999; Baylin et al., 2002). In addition, we 
obtained higher correlations for serum DHA, EPA, and 18:1t than others have obtained for 
erythrocytes (Andersen et al., 1999; Hodge et al., 2007), with the exception of one 
study (Sun et al., 2007). It is possible that intake of these fatty acids remains relatively 
consistent over time in subjects eating a Western diet, so that it is reflected in the shorter 
half-life associated with serum. The moderate correlations we found between serum DHA, 
EPA, and 18:1t measured at baseline and intake measured at the year 3 follow-up visit also 
support this hypothesis. Other factors to consider are ease of collection and degradation 
during storage. Serum fatty acids are relatively easy to collect compared with adipose tissue 
and are less prone to degradation during storage than red blood cell fatty acids (Glatz et al., 
1989; Romon et al., 1995). In addition, determining the half-life of fatty acids in various 
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tissues is very complicated. The half-life commonly cited for adipose tissue fatty acids is 
based on linoleic acid only. Individual fatty acids in different tissues have different half-lives. 
The correlations we found for serum fatty acids suggest that selecting a fatty acid biomarker 
– serum, adipose tissue, or erythrocyte – should be based on more than half-life alone.  
 This correlation study has several strengths. First, this study included more than 900 
postmenopausal women, which provided sufficient statistical power to examine correlations 
between serum and intake. However, statistical power to examine correlation among non-
whites was limited. Second, we examined the correlations for serum trans fatty acids, which 
only one study had examined previously (Sun et al., 2007). Third, we examined the 
measurement characteristics of the WHI FFQ against serum fatty acids, a biomarker of fatty 
acid intake that has measurement errors that are uncorrelated with errors in the FFQ. 
Previously, fatty acid intakes derived from the WHI FFQ were compared against other self-
reported measures (Patterson et al., 1999). Since these measures shared major sources of 
error (e.g. memory, perception of serving sizes, and nutrient database) and those errors 
were likely correlated in both measures, it is possible that a large proportion of the 
correlation was due to these errors.  
 Our study also has limitations. One concern is the stability of serum fatty acids during 
storage and freeze/thaw procedures. However, serum storage for up to 12 years at -80°C 
protected polyunsaturated fatty acids from oxidation (Zeleniuch-Jacquotte et al., 2000). We 
conducted an analysis of 15 samples that demonstrated that there were no substantial 
changes in the composition of the serum fatty acids analyzed originally in 2005, one year 
later in 2006, and then after an additional freeze/thaw procedure. No statistically significant 
differences were detected between the mean values of the fatty acids from the original and 
one-year or freeze/thaw samples. Polyunsaturated fatty acids, the most susceptible fatty 
acids to storage and freeze/thaw, gave the best results according to this analysis.  
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 Another concern is that our study population of mostly non-Hispanic Caucasian, 
postmenopausal US women is relatively homogenous, limiting generalizability to other 
populations. One correlation study of adipose tissue conducted in Costa Rica reported high 
correlations for 18:1t and linelaidic acid due to the high intake of partially hydrogenated 
soybean oil in that population (Baylin et al., 2002). Our results suggest that the correlations 
between serum DHA, EPA, and 18:1t and intake may vary by race, education, and body 
weight status. These varying correlations are likely the result of inaccurate reporting of 
intake by participants. These results emphasize the importance of examining the 
correlations of fatty acids biomarkers and intake in various populations.  
 Finally, the WHI did not collect information on intake of fish oil supplements. Correlations 
for DHA and EPA may have been underestimated by not accounting for fish oil in the intake 
in EPA and DHA. Despite the lack of data on fish oil supplementation use, our results 
indicate that serum DHA and EPA can rank participants according to intake of DHA, EPA, 
and fish.  
 In summary, in this cohort of postmenopausal US women, serum DHA, EPA, and 18:1t 
are suitable biomarkers of their corresponding dietary fatty acid intakes as assessed by an 
FFQ. Based on these moderate correlations, future studies that find associations between 
serum DHA, EPA, or 18:1t and disease may make cautious dietary recommendations. 
Future studies that find associations between dietary intake of DHA, EPA, 18:1t, fish, added 
fats, and pastries and disease are strengthened by the moderate correlations with the 
objective serum fatty acid measurements reported in this study. 
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VII. Serum Fatty Acids and the Risk of Ischemic Stroke Among  
Postmenopausal Women 
This manuscript presents the results and discusses the implications of Aim 2. It addresses 
two possibilities that could explain inconsistent findings in previous studies of fatty acids and 
ischemic stroke risk: combining fatty acids with opposing effects on CVD risk and examining 
ischemic stroke as a composite outcome despite its heterogeneous etiology. The few studies 
that had data on ischemic stoke subtypes lacked statistical power to examine those subtypes. 
Few of the previous studies included women, despite the higher burden of ischemic stroke 
among postmenopausal women. Therefore, this manuscript examines the associations between 
individual serum fatty acids and total ischemic stroke and its etiologic subtypes among a cohort 
of postmenopausal women, who have elevated risk of ischemic stroke.  
A. SUMMARY 
 Context: While epidemiologic studies have linked trans and saturated fatty acids with 
increased risk of coronary heart disease, and polyunsaturated fatty acids with decreased risk, 
few epidemiologic studies have examined associations between serum fatty acids and ischemic 
stroke.  
Objective: To examine the associations between serum fatty acid concentrations and 
incidence of ischemic stroke and its subtypes. 
Design and Setting: Prospective case-control study nested in the Women’s Health Initiative 
Observational Study cohort of postmenopausal US women aged 50 to 79 years. 
Participants: Between 1993 and 2003, incident cases of ischemic stroke were matched 1:1 
to controls on age, race, and length of follow-up (964 matched pairs).  
Main Outcome Measure: Incident  ischemic stroke and ischemic stroke subtypes. 
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Results: The multivariable odds ratio (OR) and 95% confidence interval (CI) of ischemic 
stroke associated with a 1-standard deviation (SD) increment in serum fatty acid concentration 
was 1.38 (1.17, 1.63) for linelaidic acid (18:2tt, SD=0.04%); 1.27 (1.14, 1.41) for palmitic acid 
(16:0, SD=2.74%); 1.20 (1.08, 1.33) for oleic acid (18:1n9, SD=2.32%); 0.84 (0.75, 0.93) for 
eicosapentaenoic acid (20:5n3, SD=0.54%); 0.72 (0.64, 0.80) for docosapentaenoic acid 
(22:5n3, SD=0.18%); 0.72 (0.64, 0.80) for docosahexaenoic acid (22:6n3, SD=0.91%); and 0.81 
(0.73, 0.91) for arachidonic acid (20:4n6, SD=2.02%). These associations were generally 
consistent for atherothrombotic and lacunar stroke, but not cardioembolic stroke.  
Conclusions: These findings suggest that individual serum trans, saturated, and 
monounsaturated fatty acids are positively associated with particular ischemic stroke subtypes, 
while individual n3 and n6 polyunsaturated fatty acids are inversely associated. 
B. INTRODUCTION  
Few epidemiologic studies have examined the associations between serum fatty acids, a 
biomarker of fatty acid intakes, and ischemic stroke risk (He et al., 2007). Thus far, the results 
have been inconsistent. One study conducted in Japan found that serum saturated fatty acids 
were associated with increased risk of ischemic stroke, while serum linoleic acid (an n6 
polyunsaturated fatty acid) was associated with decreased risk (Iso et al., 2002). Another study 
conducted in Finland found similar associations as the Japan study, but additionally reported 
that serum monounsaturated and n3 polyunsaturated fatty acids were associated with increased 
risk of ischemic stroke (Tilvis et al., 1987). However, a third study found no significant 
associations for serum saturated or monounsaturated fatty acids (Miettinen et al., 1986).  
Two possibilities have been raised that could explain these inconsistent findings. First, the 
associations between serum fatty acids and ischemic stroke may not be consistent for all 
ischemic stroke subtypes. In the Japan study described previously, the results were driven by 
lacunar stroke, this subtype comprising 95 of the 122 ischemic strokes in that study (Iso et al., 
2002). Importantly, this study did not have sufficient power to examine associations for 
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atherothrombotic stroke, the subtype of ischemic stroke directly related to blood 
cholesterol (Ohira et al., 2006). Combining atherothrombotic stroke with lacunar and 
cardioembolic strokes would dilute expected associations. However, to our knowledge, only one 
study has examined serum fatty acids in relation to atherothrombotic stroke and other ischemic 
stroke subtypes.  
Second, the inconsistent findings could be due to individual fatty acids having different 
effects on ischemic stroke. In the Japan study described previously, despite finding that serum 
myristic and palmitic, but not stearic, saturated fatty acids were positively associated with total 
ischemic stroke in unadjusted analysis, investigators combined these three fatty acids in 
multivariable analysis (Iso et al., 2002). Depending on the relative contribution of each fatty acid, 
it is possible to find inconsistent associations for total serum saturated fatty acids. However, few 
studies have examined serum fatty acids individually while controlling for potential confounders. 
To address these possibilities, we conducted a prospective case-control study nested in a 
large cohort of postmenopausal US women to examine the associations between 25 individual 
serum fatty acid concentrations from stored serum samples collected at baseline and the 
incidence of ischemic stroke and ischemic stroke subtypes. We hypothesize that individual 
serum trans and saturated fatty acids would be positively associated with atherothrombotic 
stroke, whereas individual serum monounsaturated and polyunsaturated fatty acids would be 
inversely associated. 
C. METHODS 
1. Study Population 
 We conducted a case-control study of 964 incident ischemic stroke cases and 964 matched 
control subjects nested within the Women’s Health Initiative Observational Study (WHI-
OS) (Wassertheil-Smoller et al., 2008). Briefly, the WHI was conducted in 40 clinical centers 
across the US to examine the impact of a number of factors on the major causes of morbidity 
and mortality in postmenopausal women (Prentice et al., 1998). Eligible women were 50 to 79 
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years of age at baseline, postmenopausal, had no medical conditions associated with a 
predicted survival of <3 years, and provided informed consent to be a part of the study as 
approved by the institutional review boards. The WHI-OS enrolled 93,676 women between 
October 1993 and December 1998. There were 972 confirmed incident ischemic stroke cases 
between 1993 and 2003. Control subjects were individually matched 1:1 to the cases on age 
and race at the time of ischemic stroke. Blood quantity was not sufficient to analyze fatty acid 
content for 9 participants, leaving a total of 964 case-control pairs. 
2. Case identification and classification 
Incident ischemic strokes during the follow-up period were identified through self-report 
during annual medical history updates (annual response rate 94%) (Curb et al., 2003). Using 
additional details from medical charts, brain imaging, or death certificates, the potential 
outcomes were subject to local adjudication by physicians, then central adjudication by trained 
neurologists, according to standard criteria. Over 95% of participant-reported stroke cases were 
classified based on CT or MRI findings (Chen et al., 2008). 
Central adjudicators further classified ischemic strokes by subtypes according to the Trial of 
ORG 10172 Acute Stroke Trial (TOAST) Classification (Goldstein et al., 2001). The TOAST 
classification focuses on the presumed underlying stroke mechanism; requires detailed 
investigations (such as brain computed tomography, magnetic resonance imaging, angiography, 
carotid ultrasound, and echocardiography); and distinguishes 5 categories of stroke, which 
include large artery atherothrombotic stroke, small vessel lacunar stroke, cardioembolic stroke, 
other, and undetermined mechanism (Wassertheil-Smoller et al., 2003). Probable and possible 
subtypes determinations were combined in this report. Transient ischemic attack, hemorrhagic 
stroke, strokes not requiring hospitalization, and strokes not confirmed by central adjudication 
were not included as a stroke outcome. 
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3. Control selection 
Controls were sampled from women at risk at the time ischemic stroke events occurred 
during the follow-up period and matched 1:1 to case subjects on age at baseline (±2 years), 
race/ethnicity (white, black, Hispanic, Asian, American Indian, or other/unspecified), date of 
study enrollment (±3 months), and follow-up time. 
4. Data collection 
Fasting blood samples were collected from all WHI-OS participants by clinic staff members 
following a standardized protocol for ventipuncture at baseline (Anderson et al., 2003). Samples 
were centrifuged, separated by layers, frozen onsite at -70°C, and shipped to the central WHI 
repository for long-term storage.  
Fatty acids were extracted according to the general technique of Bligh and Dyer using 1, 2-
dinonadecanoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids, Inc. Alabaster, AL) (50 µg of 
19:0) as an internal standard (Bligh & Dyer, 1959). The lipid extracts were resuspended in 1.5 
ml 14% boron trifluoride methanol and derivatized according to the procedure of Morrison and 
Smith (Morrison & Smith, 1964). The extracts were analyzed by capillary GC:column (SP-2380, 
105 m x 53 mm ID, 0.20 um film thickness). The gas chromatograph was a Perkin Elmer Clarus 
500 equipped with a flame ionization detector. Operating conditions: the oven temperature was 
140°C for 35 min, then ramped at 8°C/min to 220°C, and held for 12 min. Injector and detector 
temperatures were both at 260°C and helium, the carri er gas, was at 15 psi. Identification of 
components was by comparison of retention times with those of authentic standards (Sigma 
Chemical Co., St. Louis, MO). Duplicate samples and control pools were analyzed with each 
batch of samples. The coefficients of variation of fatty acids ranged from 3.1% to 13.2%. The 
Spearman correlation coefficients between dietary fatty acid intake (% of total fat intake 
assessed by a FFQ) and serum fatty acid concentrations among non-cases (both measured at 
baseline) were 0.53 for DHA, 0.42 for EPA, 0.18 for DPA, 0.16 for palmitic acid, 0.15 for 
linelaidic acid, 0.07 for arachidonic acid, and 0.03 for oleic acid. 
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Participants completed sociodemographic and lifestyle questionnaires during baseline visits 
to a WHI clinical center. (Anderson et al., 2003). Physical activity was assessed based on 
participant report about the frequency, intensity, and duration of walking, exercise, or 
recreational activity and summarized into total metabolic equivalent task (MET)-hours per week. 
Certified clinic staff measured participant height, weight, and blood pressure. Height and weight 
were measured without shoes or heavy clothing and with pocket contents removed. Body mass 
index (BMI) was calculated by dividing weight in kilograms by the square of height in meters. 
Following standardized procedures, blood pressure was measured twice after a 5-minute 
seated rest with a 30-second rest in between. The average of two blood pressure 
measurements was used in analysis. Hypertension was defined as self-report of 
antihypertensive medication use or systolic blood pressure ≥ 140 mm Hg or a diastolic blood 
pressure ≥ 90 mm Hg. Diabetes was defined as being on treatment for diabetes by self-report or 
having a fasting glucose level ≥ 126 mg/dL. Participants reported their history of smoking, 
diabetes, atrial fibrillation, angina, or revascularization (coronary bypass surgery or angioplasty 
of the coronary arteries), as well as current use of medications.  
 Lipoprotein profiles were assayed at Liposcience using nuclear magnetic resonance. Low-
density lipoprotein (LDL) cholesterol was calculated from high-density lipoprotein (HDL) 
cholesterol, total cholesterol, and triglyceride concentrations among women who had a 
triglyceride value <400 mg/dL using the Friedewald equation (National Cholesterol Education 
Program Expert Panel on Detection, 2002). LDL cholesterol values were set to missing for those 
women whose triglyceride value was >400 mg/dL (n=35) or who were missing HDL cholesterol, 
total cholesterol, or triglyceride values (n=7).  
5. Statistical analysis 
The McNemar’s chi-square test was used to compare covariate proportions between 
ischemic stroke cases and controls. The paired Student’s t test was used to compare serum 
fatty acid concentration and covariate means between ischemic stroke cases and controls. The 
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distributions of the serum fatty acids were highly skewed to the right. Therefore, we used the 
median as the measure of central tendency for descriptive statistics. 
Conditional logistic regression was used to estimate odds ratios (OR) and 95% confidence 
intervals (CI) for ischemic stroke and its subtypes, conditioning on matching factors in all 
models. We divided women into quintiles based on distribution of serum fatty acid 
concentrations in the case-control study population. We estimated multivariable ORs and 95% 
CIs comparing the odds of ischemic stroke among women in the higher quintiles of serum fatty 
acids with the odds of ischemic stroke in the first quintile. Linear trend tests were performed by 
assigning the median value of the quintile of the fatty acid to each category and entering this 
variable into the model as a continuous variable. Since trends were generally linear, 
multivariable ORs were calculated per 1-standard deviation (SD) increment in each fatty acid. 
Covariates were determined using previous knowledge, existing literature, and statistical tests. 
Our primary model was adjusted for BMI, smoking status, diabetes, and aspirin use. 
Subsequent models were adjusted for blood pressure and blood cholesterol variables, since 
these factors are the likely mediators of the association between serum fatty acids and ischemic 
stroke. Two-sided P ≤ 0.001 was considered significant to account for multiple comparisons and 
to decrease the risk of detecting a false positive association (Type I error). All analyses were 
performed using SAS statistical software (Version 9.2, SAS Institute Inc., Cary, NC, USA). 
D. RESULTS 
1. Study Population 
Between 1993 and 2003, we identified 964 cases of incident ischemic stroke. Of these, 96 
were atherothrombotic strokes, 250 were lacunar strokes, 209 were cardioembolic strokes, 42 
were ischemic strokes of other determined etiology, 366 were ischemic strokes of undetermined 
etiology, and 1 was missing subtype information. The mean age at baseline of women with 
ischemic stroke was 68.7 (SD 6.4) years (Table 12). Women with incident ischemic stroke were 
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more likely to be overweight or obese, be a current smoker, have diabetes, and to use aspirin. 
We accounted for these differences by adjusting for these variables in multivariable analysis. 
2. Distribution of serum fatty acids 
Twenty-five individual serum fatty acids were examined (Table 13). The major contributors 
(median >5%) to the composition of serum fatty acids were linoleic n6 polyunsaturated (27%), 
palmitic saturated (24%), oleic monounsaturated (18%), stearic saturated (9%), and arachidonic 
n6 polyunsaturated (8%) fatty acids. The serum concentrations of 18:1t and linelaidic trans fatty 
acids, myristic and palmitic saturated fatty acids, and 7-hexadecenoic and oleic 
monounsaturated fatty acids were higher among ischemic stroke cases than controls. The 
concentrations of alpha-linolenic, eicosatetraenoic, EPA, DPA, DHA n3 polyunsaturated fatty 
acids and linoleic, arachidonic, and 22:5n6 n6 polyunsaturated fatty acids were lower among 
ischemic stroke cases than controls. 
3. Total ischemic stroke 
With adjustment for BMI status, smoking status, diabetes, and aspirin use and accounting 
for the matching factors, serum linelaidic acid (18:2tt trans, SD=0.04%, OR 1.38, 95%CI 1.17 to 
1.63), palmitic acid (16:0 saturated, SD=2.74%, OR 1.27, 95%CI 1.14 to 1.41), and oleic acid 
(18:1n9 monounsaturated, SD=2.32%, OR 1.20, 95%CI 1.08 to 1.33) were associated with 
increased incidence of ischemic stroke.  Serum EPA (20:5n3 n3 polyunsaturated, SD=0.54%, 
OR 0.84, 95%CI 0.75 to 0.93), DPA (22:5n3 n3 polyunsaturated, SD=0.18%, OR 0.72, 95%CI 
0.64 to 0.80), DHA (22:6n3 n3 polyunsaturated, SD=0.91%, OR 0.72, 95%CI 0.64 to 0.80) n3 
polyunsaturated fatty acids and arachidonic (20:4n6 n6 polyunsaturated, SD=2.02%, OR 0.81, 
95%CI 0.73 to 0.91) acid were associated with decreased incidence (Figure 7, Table 14). 
Further adjustment for blood pressure and blood cholesterol did not change estimates by more 
than 10%. Neither did further adjustment for physical activity, angina, atrial fibrillation, or 
revascularization change estimates by more than 10% (data not shown). 
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To examine the possibility that the positive association for serum oleic acid was due to its 
correlations with serum arachidonic acid or serum DHA (Spearman rank correlation 
coefficients -0.43 and -0.31, respectively), we additionally adjusted for these fatty acids using 
the residual method (Willett, 1998). The multivariable OR (95%CI) for total ischemic stroke 
associated with a 1-SD increment in oleic acid was attenuated by 10% (OR 1.09, 95% CI 1.00, 
1.18) after adjustment for serum arachidonic acid, by 12% (OR 1.06, 95% CI 0.99, 1.14) after 
adjustment for serum DHA, and completely attenuated after adjustment for serum total 
polyunsaturated fatty acids (OR 1.00, 95% CI 0.91, 1.11). 
4. Ischemic stroke subtypes 
We further examined the fatty acids that were significantly associated with total ischemic 
stroke (serum linelaidic acid, palmitic acid, oleic acid, EPA, DPA, DHA, and arachidonic acid) in 
relation to ischemic stroke subtypes. The associations between these serum fatty acids and 
total ischemic stroke were generally consistent for atherothrombotic stroke, lacunar stroke, and 
ischemic stroke of undetermined etiology (Figure 8, Table 15). There were a few exceptions to 
this generalization. We did not observe a positive association between palmitic acid and 
atherothrombotic stroke. Neither did we observe an inverse association between EPA and 
ischemic strokes of undetermined etiology. However, we did observe an inverse association 
between serum DHA and cardioembolic stroke, making DHA the only serum fatty acid to be 
consistently inversely associated with all subtypes of ischemic stroke. We did not have sufficient 
statistical power to examine associations for ischemic strokes of other determined etiology (42 
matched pairs). 
Further adjustment for blood pressure attenuated associations for lacunar stroke (by 11% for 
EPA and 12% for DHA), but not atherothrombotic stroke. Further adjustment for blood 
cholesterol attenuated associations for lacunar stroke (by 13% for linelaidic fatty acid) and 
atherothrombotic stroke (by 48% for linelaidic fatty acid, 28% for palmitic fatty acid, and 60% for 
oleic fatty acid). 
  58
E. DISCUSSION 
 In the largest case-control study of ischemic strokes among postmenopausal US women, 
serum linelaidic (trans) acid, palmitic (saturated) acid, and oleic (monounsaturated) acid were 
associated with increased incidence of ischemic stroke. Serum EPA, DPA, and DHA (n3 
polyunsaturated) acids and arachidonic (n6 polyunsaturated) acid were associated with 
decreased incidence. These associations were generally consistent for atherothrombotic and 
lacunar stroke, but not cardioembolic stroke. 
 Our results suggest that individual serum fatty acids have different associations with 
ischemic stroke. However, large prospective cohort studies were not able to examine fatty acids 
individually. These studies assessed fatty acid intake through participant report (e.g. FFQ) and 
focused on major types of fat (e.g., saturated fat). Two prospective studies reported that 
saturated fat intake and animal fat intake (mostly saturated fat) were associated with decreased 
risk of ischemic stroke and cerebral infarction death, respectively (Gillman et al., 1997; 
Sauvaget et al., 2004). However, four prospective studies failed to find associations between 
saturated fat intake and ischemic stroke (Seino et al., 1997; Iso, Stampfer, et al., 2001; He et al., 
2003; Yaemsiri et al., 2012 [in press]). One possible explanation for these inconsistent results is 
that individual fatty acids, even those of the same type, may have different effects on 
cardiovascular disease risk. For example, myristic (14:0) and palmitic (16:0) acids tend to 
increase plasma total and LDL-cholesterol concentrations compared with oleic acid, whereas 
stearic acid (18:0) does not (Kris-Etherton & Yu, 1997). It is possible that examining types of fat 
intake masked the associations of individual fatty acids and ischemic stroke. However, individual 
fatty acids were highly correlated in prospective studies due to participant reported intake 
assessment methods. These high correlations make distinguishing their individual relations with 
ischemic stroke risk difficult (Hu et al., 2001). 
 In contrast to the prospective studies using participant reported fatty acids intakes, case-
control studies using biomarkers of fatty acid intake – serum, erythrocytes, and adipose tissue – 
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are able to examine fatty acids individually (e.g., palmitic acid). In the largest of these studies, 
Iso and colleagues found that serum myristic and palmitic acids, but not stearic acid, were 
associated with increased risk of ischemic stroke, even though all three are saturated fatty 
acids. (Iso et al., 2002). In addition, serum linoleic acid, but not other polyunsaturated fatty 
acids, was associated with decreased risk of ischemic stroke. Smaller case-control studies also 
suggest that individual fatty acids, even those of the same type, may have different effects on 
ischemic stroke risk (Bucalossi & Mori, 1972; Miettinen et al., 1986; Ricci et al., 1987; Ricci et 
al., 1997). These studies highlight the importance of examining individual fatty acids in relation 
to ischemic stroke risk.  
 Our results also suggest that the associations between serum fatty acids and ischemic 
stroke may not be consistent across all ischemic stroke subtypes. To our knowledge, only two 
studies have reported associations for ischemic stroke subtypes. In these studies, the 
associations between individual fatty acids and total ischemic stroke were consistent for lacunar 
stroke, but not atherothrombotic or cardioembolic stroke. Iso and colleagues reported that the 
associations between serum saturated and linoleic fatty acids and ischemic stroke were driven 
by lacunar stroke, this subtype comprising 95 of the 122 ischemic strokes in that study (Iso et 
al., 2002). More recently, Yaemsiri and colleagues reported that the positive association 
between trans fat intake and ischemic stroke was consistent for lacunar stroke using data from 
the full WHI-OS cohort in a longitudinal study (Yaemsiri et al., 2012 [in press]). These studies 
highlight the importance of examining ischemic stroke subtypes individually.  
The associations between fatty acids and ischemic stroke may not be consistent across all 
subtypes because ischemic stroke is a heterogeneous condition. There is evidence that blood 
cholesterol may play a role in the development of some ischemic stroke subtypes, but not 
others (Ohira et al., 2006). Kuller and Reisler examined the incidence of ischemic stroke 
subtypes in populations with varying blood cholesterol levels (Kuller & Reisler, 1971). Based on 
this analysis, they hypothesized that blood cholesterol may play a role in atherothrombotic 
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stroke, the ischemic stroke subtype with an atherogenic basis. Fatty acid intakes have a 
powerful effect on blood cholesterol concentrations, and they were hypothesized to play a role 
in the development of atherothrombotic stroke, as well. One of the challenges in studying 
atherothrombotic stroke, the least prevalent ischemic stroke subtype, is low statistical power. 
However, we had sufficient power to detect general trends in atherothrombotic stroke incidence 
according to serum fatty acid concentration. Consistent with Kuller and Reisler’s hypothesis, 
linelaidic, oleic, EPA, DPA, DHA, and arachidonic acids were associated with atherothrombotic 
stroke.  
While the effect of fatty acid intake on blood cholesterol likely explains associations for 
atherothrombotic stroke, the explanation for the apparent associations for lacunar stroke is not 
clear. However, a few possibilities can be proposed. First, intake of EPA and DHA through fish 
oil supplementation may lower blood pressure. A meta-analysis of 36 randomized trials reported 
that fish oil supplementation lowered systolic and diastolic blood pressures by 3.5 and 2.4 mm 
Hg, respectively (Geleijnse et al., 2002). Importantly, serum DHA, which may have a stronger 
blood pressure lowering effect than EPA, (Mori et al., 1999) was the only serum fatty acid that 
was consistently associated with all subtypes of ischemic stroke in the present study. Second, 
intake of EPA and DHA inhibit thrombosis through their anti-platelet effects (Agren et al., 1997). 
In the present study, serum EPA and DHA were both inversely correlated with d-dimer 
concentration, a measure of thrombotic disease, such as lacunar stroke. Third, intake of trans 
fat intake and n3 polyunsaturated fatty acids have pro- and anti-inflammatory effects, 
respectively (James et al., 2000; Mozaffarian et al., 2004). High concentrations of inflammatory 
markers have been associated with greater neurological deterioration in lacunar 
strokes (Castellanos et al., 2002). Finally, there is limited evidence suggesting that trans fat 
intake may adversely affect glucose tolerance, which may lead to development of diabetes. 
Diabetes is a major risk factor for lacunar stroke. Most observational studies report a positive 
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association between trans fat intake and diabetes, however these results have not been 
supported by the results of controlled feeding studies (Thompson et al., 2011). 
Our study has some limitations. One concern is the stability of serum fatty acids during 
storage and freeze/thaw procedures. However, serum storage for up to 12 years at -80°C 
protected polyunsaturated fatty acids, the most susceptible fatty acids to storage and freeze-
thaw, from oxidation (Zeleniuch-Jacquotte et al., 2000). We conducted an analysis of 15 
samples analyzed originally in 2005, one year later in 2006, and then after an additional 
freeze/thaw procedure. No statistically significant differences were detected between the mean 
values of the fatty acids from the original and one-year or freeze/thaw samples. 
When these ischemic strokes were classified, TOAST was the best currently available with 
moderate to good inter-observer reliability with training (Wassertheil-Smoller et al., 2003). The 
field of ischemic stroke classification has been evolving to address the large number of cases 
that are classified as having “undetermined etiology.” In the newer ASCO Phenotypic System, 
cases can be characterized by all 4 phenotypes based on the level of diagnostic 
certainty (Shang & Liu, 2012). Using the ASCO classification could reduce the proportion of 
ischemic stroke cases with underdetermined etiology and increase statistical power.  
Another concern is that the TOAST classification uses a history of diabetes mellitus and 
hypertension in its lacunar stroke definition (Adams et al., 1993). This classification bias could, 
in part, explain the association between serum fatty acid and lacunar stroke, assuming that 
serum fatty acids act through hypertension to increase risk of ischemic stroke. More recent 
studies have advocated the use of a “risk factor-free classification” to avoid classification 
bias (Ohira et al., 2006). However, the prevalence of hypertension among the ischemic stroke 
subtypes was relatively uniform (72% of atherothrombotic, 73% of lacunar, and 68% of 
cardioembolic stroke cases) suggesting that this misclassification was not a major source of 
bias in this study.  
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Finally, there is evidence that associations between fatty acid biomarkers and ischemic 
stroke may vary by the age of the study population and type of biomarker used (Tilvis et al., 
1987). The results derived from this study population of predominately white postmenopausal 
women may not be generalizable to other populations. 
 In conclusion, we report that serum linolaidic trans fatty acid, palmitic saturated fatty acid, 
and oleic monounsaturated fatty acid were positively associated with incidence of ischemic 
stroke, while serum EPA, DPA, DHA n3 polyunsaturated fatty acids and arachidonic n6 
polyunsaturated fatty acid were inversely associated with incidence of ischemic stroke. These 
associations were generally consistent for atherothrombotic and lacunar strokes. These findings 
highlight the importance of individual fatty acids in the development of particular subtypes of 
ischemic stroke. 
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VIII. CONCLUSIONS 
 The goal of this dissertation was to answer the questions: Why were there discrepancies 
in previous studies relating fatty acid biomarkers versus fatty acid intakes to ischemic stroke 
and why were there discrepancies in previous studies relating dietary fat intake to ischemic 
stroke versus CHD? We examined the correlations between serum fatty acids and fatty acid 
intakes to answer the first question. We examined the associations between individual 
serum fatty acids and ischemic stroke subtypes to answer the second question.  
A. Aim 1 conclusions 
1. Individual fatty acid correlations 
In this study, we found moderate correlations between serum fatty acid concentration 
and fatty acid intakes for DHA, EPA, and 18:1t fatty acids. Thus, we expected to find 
consistent associations between these serum fatty acids and fatty acid intakes and ischemic 
stroke. However, studies relating intake to ischemic stroke focused on fatty acid groups, 
rather than individual fatty acids. They did not examine fatty acids individually because they 
measured fat intake through participant report (e.g. FFQ and 24-hour recall). These methods 
may result in high correlations among individual fatty acids within the same group, making 
distinguishing their individual relations with disease risk difficult (Hu et al., 2001). Therefore, 
we investigated the correlations between individual serum fatty acids and fatty acid intake 
groups. 
2. Fat group correlations 
 The correlations between serum fatty acids and fat intake groups help explain previous 
inconsistent results. With respect to fat intake groups, we found a moderate correlation 
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between serum 18:1t fatty acid and trans fat intake and between serum DHA and EPA and 
n3 polyunsaturated fat intake. Thus, we expected to find consistent associations between 
these fatty acids measured in serum and diet and ischemic stroke. Indeed, the positive 
associations between serum 18:1t fatty acid and ischemic stroke in this dissertation were 
consistent with the positive associations found between trans fat intake and ischemic 
stroke (Yaemsiri et al., 2012 [in press]). In addition, the inverse associations between serum 
DHA and EPA and ischemic stroke in this dissertation were consistent with the inverse 
associations found between n3 polyunsaturated fat intake and ischemic stroke (Iso, 
Rexrode, et al., 2001; He et al., 2002). 
 We found low correlations between serum DHA and EPA and total polyunsaturated fat 
intake. Given these low correlations, consistent results between DHA and EPA versus total 
polyunsaturated fat intake and ischemic stroke should not be expected. Indeed, the inverse 
associations between serum DHA and EPA and ischemic stroke in this dissertation were 
consistent with studies that examined DHA and EPA (specifically) and ischemic stroke (Iso, 
Rexrode, et al., 2001; He et al., 2002), but not consistent with the studies that examined 
total polyunsaturated fatty acids and ischemic stroke (Gillman et al., 1997; Seino et al., 
1997; He et al., 2003; Sauvaget et al., 2004).  
 In summary, studies that examined total polyunsaturated fat intake reported null 
associations with ischemic stroke (Gillman et al., 1997; Seino et al., 1997; He et al., 2003; 
Sauvaget et al., 2004), while studies that examined n3 polyunsaturated fatty acids 
specifically reported significant inverse associations (Iso, Rexrode, et al., 2001; He et al., 
2002). The implication for future studies is that studies should examine the associations 
between individual fatty acid intakes and disease, not fat intake groups. Combining fatty 
acids into groups, in particular combining n3 and n6 polyunsaturated fatty acids, could mask 
any potential association of individual fatty acids, depending on their relative contribution.  
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3. Serum biomarker of fatty acid intakes 
Adipose tissue and erythrocyte fatty acids are often thought to be better biomarkers of 
long-term fatty acid intake than serum based on the longer half-lives of fatty acids in these 
tissues (Sun et al., 2007). However, based on our results and that of others,’ serum DHA, 
EPA, and 18:1t fatty acids have correlations with long-term intake that are similar to or better 
than those reported for adipose tissue (Hunter et al., 1992; Tjonneland et al., 1993; Garland 
et al., 1998; Lemaitre et al., 1998; Andersen et al., 1999; Baylin et al., 2002) and 
erythrocytes (Andersen et al., 1999; Hodge et al., 2007; Sun et al., 2007). Since adipose 
tissue fatty acids are more difficult to collect and erythrocyte fatty acids are prone to 
degradation during storage (Glatz et al., 1989; Romon et al., 1995), serum may be a good 
alternative to rank participants according to intake of DHA, EPA and 18:1t fatty acids. 
4. Implications for future research 
 The moderate correlations found between serum DHA, EPA, and 18:1t fatty acids and 
their corresponding fatty acid intake, fat intake groups, and food groups have implications 
for future studies. Those that find associations between serum concentration of DHA, EPA, 
or 18:1t fatty acids and disease may make cautious dietary recommendations based on 
these moderate correlations. Those that find associations between dietary intake of DHA, 
EPA, 18:1t fatty acid, fish, and added fats and disease are strengthened by the moderate 
correlations with the objective serum fatty acid measurements reported in this study. 
 We found that serum DHA, EPA, and 18:1t fatty acids were suitable biomarkers of their 
corresponding fatty acid intake. However, the correlations between serum and intake of 
thirteen other fatty acids were low. This work highlights the need for further research to find 
suitable biomarkers of intake for several fatty acids, especially specific saturated fatty acids, 
which are associated with increased risk of ischemic stroke. 
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B. Aim 2 conclusions 
1. Total ischemic stroke 
 In this study, serum linelaidic, palmitic, and oleic acids were positively associated, and 
serum EPA, DPA, DHA, and arachidonic acids were inversely associated, with ischemic 
stroke. Based on studies of dietary fat groups and coronary heart disease, we expected that 
trans and saturated fatty acids would be positively associated with ischemic stroke and 
monounsaturated and polyunsaturated fatty acids inversely associated with ischemic stroke. 
However, not all individual serum fatty acids within a fatty acid group followed these 
associations. For example, serum 18:1t fatty and linelaidic acids were positively associated 
with ischemic stroke, while palmitelaidic acid showed no association. Similarly, myristic and 
palmitic acids were positively associated with ischemic stroke, while pentanoic, margaric, 
and stearic acids showed no association. These results further support our recommendation 
that future studies examine associations between individual fatty acid intakes and disease, 
not fatty acid groups. 
 Few studies have examined the associations between trans fatty acids and ischemic 
stroke; none used a biomarker of trans fatty acid intake. Two prospective studies of trans fat 
intake among male and female health care professionals did not find significant associations 
with ischemic stroke after adjustment for potential confounders (Iso, Stampfer, et al., 2001; 
He et al., 2002). However, a longitudinal prospective study of ischemic stroke in the WHI-OS 
observed that women in the highest quartile of trans fat intake were 39% more likely to 
experience ischemic stroke compared with women in the lowest. Our results support the 
available evidence that 18:1t fatty acid and linelaidic acid, the trans fatty acids found in 
partially hydrogenated vegetable oils, have stronger cardiovascular disease effects than 
palmitelaidic acid (Mozaffarian et al., 2009). 
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 One unexpected result was the positive association between serum oleic acid and total 
ischemic stroke, given oleic acid’s neutral effect on serum cholesterol  (Mensink & Katan, 
1992) and beneficial effect on blood pressure (Teres et al., 2008). We suggest one 
possibility that could explain this unexpected association. Serum fatty acids are expressed 
as a percent of total fatty acids, not absolute amounts. Therefore, increases of a specific 
fatty acid can drive down the relative percentage of another fatty acid even though its 
absolute amount is unaltered. Serum oleic acid was inversely correlated with arachidonic 
acid and DHA, suggesting that increased concentration of serum oleic acid drove down 
concentrations of DHA and arachidonic fatty acids. Both DHA and arachidonic fatty acids 
were inversely associated with ischemic stroke. When we statistically remove these 
correlations, the association between oleic acid and ischemic stroke was attenuated. The 
oleic acid finding may be a result of examining serum fatty acid concentrations rather than 
absolute amounts. Still, with the opposing effects of individual fatty acids, the concentration 
of fatty acids, rather than the absolute amount appears to be important to cardiovascular 
disease risk (Hu et al., 1997). 
2. Ischemic stroke subtypes 
 Our results also suggest that the associations between serum fatty acids and ischemic 
stroke may not be consistent across all ischemic stroke subtypes. To our knowledge, only 
two studies have reported associations for ischemic stroke subtypes. In these studies, the 
associations were consistent for lacunar stroke, but not atherothrombotic or cardioembolic 
stroke. Iso and colleagues reported that the associations between serum saturated and 
linoleic fatty acids and ischemic stroke were driven by lacunar stroke, this subtype 
comprising 95 of the 122 ischemic strokes (Iso et al., 2002). More recently, Yaemsiri and 
colleagues reported that the positive association between trans fat intake and ischemic 
stroke was consistent for lacunar stroke using data from the full WHI-OS cohort in a 
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longitudinal study (Yaemsiri et al., 2012 [in press]). These studies highlight the importance of 
examining ischemic stroke subtypes individually.  
 The associations between fatty acids and ischemic stroke may not be consistent across 
all subtypes because ischemic stroke is a heterogeneous condition. There is evidence that 
serum cholesterol may play a role in the development of some ischemic stroke subtypes, but 
not others (Ohira et al., 2006). Kuller and Reisler examined the incidence of ischemic stroke 
subtypes in populations with varying serum cholesterol levels (Turan et al., 2010). Based on 
this analysis, they hypothesized that serum cholesterol may play a role in atherothrombotic 
stroke, the ischemic stroke subtype with an atherogenic basis. Fatty acid intakes have a 
powerful effect on serum cholesterol concentrations, and they were hypothesized to play a 
role in the development of atherothrombotic stroke, as well. One of the challenges in 
studying atherothrombotic stroke, the least prevalent ischemic stroke subtype, is low 
statistical power. However, we had sufficient power to detect general trends in 
atherothrombotic stroke incidence according to serum fatty acid concentration. Consistent 
with Kuller and Reisler’s hypothesis, linelaidic, oleic, EPA, DPA, DHA, and arachidonic acids 
were associated with atherothrombotic stroke.  
 While the effect of fatty acid intake on serum cholesterol likely explains associations for 
atherothrombotic stroke, the mechanisms for the apparent associations for lacunar stroke 
are not clear. However, a few possibilities can be proposed. First, intake of EPA and DHA 
through fish oil supplementation may lower blood pressure. A meta-analysis of 36 
randomized trials reported that fish oil supplementation lowered systolic and diastolic blood 
pressures by 3.5 and 2.4 mm Hg, respectively (Geleijnse et al., 2002). Importantly, serum 
DHA, which may have a stronger blood pressure lowering effect than EPA (Mori et al., 
1999), was the only serum fatty acid that was consistently associated with all subtypes of 
ischemic stroke in the present study. Second, intake of EPA and DHA inhibit thrombosis 
through their anti-platelet effects (Agren et al., 1997). In the present study, serum EPA and 
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DHA were both inversely correlated with d-dimer concentration, a measure of thrombotic 
disease, such as lacunar stroke. Third, intake of trans fat intake and EPA and DHA have pro- 
and anti-inflammatory effects, respectively (James et al., 2000; Mozaffarian et al., 2004). 
High concentrations of inflammatory markers have been associated with greater 
neurological deterioration in lacunar strokes (Castellanos et al., 2002). Finally, there is 
limited evidence suggesting that trans fat intake may adversely affect glucose tolerance, 
diabetes being a key risk factor for lacunar stroke. Most observational studies report a 
positive association between trans fat intake and diabetes, however these results have not 
been supported by the results of controlled feeding studies (Thompson et al., 2011). 
 With the exception of serum DHA, serum fatty acids were not associated with 
cardioembolic stroke. It could be that hypertension and serum cholesterol are more distal 
causes of cardioembolic stroke than lacunar and atherothrombotic stroke. More proximate 
causes include atrial fibrillation, cardiac valve disease, or recent myocardial infarction. 
Indeed, serum DHA, which has been shown to reduce risk of atrial fibrillation in some 
studies, was inversely associated with cardioembolic stroke. These other more proximate 
causes of cardioembolic stroke may be unrelated to serum fatty acids. 
Two fatty acids stand out for being associated with a subtype of ischemic stroke, but 
having no detectable association with total ischemic stroke. The first was serum stearic acid, 
which was inversely associated with lacunar stroke, but not total ischemic stroke or other 
subtypes. Serum stearic acid has been linked with lower systolic (Leng et al., 1994) and 
diastolic blood pressures (Simon et al., 1996), which is the primary cause of lacunar strokes. 
The second was serum alpha-linolenic acid, which was inversely associated with 
cardioembolic stroke, but not total ischemic stroke or other subtypes. The alpha-linolenic 
acid-rich Mediterranean diet has been linked with a reduction in recurrent myocardial 
infarction (de Lorgeril et al., 1994), which is a prim
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results show that combining ischemic strokes with different etiologies may mask 
associations between individual fatty acids and ischemic stroke subtypes.   
 There is some controversy about whether lacunar strokes should be investigated 
separately from other ischemic strokes in epidemiologic studies based on their association 
with risk factors. In an investigation of risk factors of ischemic stroke subtypes, Ohira and 
colleagues reported that the population attributable fractions (PAF) of diabetes and current 
smoking was twice as great for lacunar versus non-lacunar stroke. However, the PAF of 
hypertension was around 35% for all ischemic stroke subtypes (Ohira et al., 2006). In 
contrast, another study using risk factor-free definitions of ischemic stroke subtypes found 
only a marginal excess of hypertension and no difference for diabetes with lacunar vs. non-
lacunar strokes (Jackson & Sudlow, 2005). Our results suggest something different entirely, 
that cardioembolic stroke should be investigated separately from atherothrombotic and 
lacunar strokes.  
3. Implications for future research 
 We found that not all serum fatty acids in the same group have the same association 
with ischemic stroke. These results suggest that fatty acids should be examined individually 
with respect to ischemic stroke, and likely other cardiovascular diseases. The effect of 
combining individual fatty acids into groups is to dilute the association of fatty acids that are 
associated with disease. Studies using participant report of intake through an FFQ will find 
examining individual fatty acids difficult because of the correlations between fatty acids of 
the same type. These methods may be improved to better distinguish between individual 
fatty acids or other measures of fatty acid intake may be used, such as a tissue biomarker of 
fatty acid intake.  
 In addition, we found that the associations between serum fatty acids were not 
consistent across ischemic stroke subtypes. These results suggest that ischemic strokes 
should be examined by subtype, especially for exposures related to serum cholesterol. This 
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work highlights the need for studies with a large number of ischemic strokes. The barriers to 
examining ischemic stroke subtypes are having the brain imaging data to classify ischemic 
strokes and having a sufficient number of ischemic strokes so that examination of subtypes 
will have sufficient statistical power. It may be useful to conduct meta-analyses or pooling 
studies in order to combine data from several studies to examine ischemic stroke subtypes.  
C. Dietary recommendations 
 In this dissertation, we report inverse associations between serum DHA and EPA and 
ischemic stroke. In addition, we report that serum DHA and EPA are correlated with their 
corresponding dietary fat intakes, as well as fish intake. While these associations are not 
causal and should be investigated in an experimental setting, these results suggest that 
intake of DHA and EPA or fish may reduce ischemic stroke risk. 
 Intake of DHA and EPA through fish oil supplementation has been shown to beneficially 
influence cardiovascular risk factors. Fish oil supplementation lowers serum triglyceride 
concentrations by 25% to 30% and raises HDL cholesterol concentrations by 3% (Harris, 
1997). Fish oil supplementation also lowers blood pressure, a major risk factor of ischemic 
stroke (Geleijnse et al., 2002). In addition to being a major source of dietary DHA and EPA, 
fish is an excellent source of protein, vitamins, and trace elements. 
 The results of this dissertation add to the body of literature suggesting that we should 
avoid 18:1t intake. A trans fatty acid, 18:1t has no nutritional benefit and potential to 
harm (Mozaffarian et al., 2006). The FDA suggests that you keep trans fat intake as low as 
possible. Since 2003, the FDA has required the labeling of trans fats in foods. The problem 
is if a food has <0.5g trans fat then food label can read 0g of fat. However, we found that 
even small amounts of trans fat may associated with increased odds of stroke. So it is best 
to avoid the commercially prepared baked and fried goods that use trans fats. Since many 
foods don’t have labels, this points to a need for big changes in the food and restaurant 
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industry. Many manufacturers and restaurants have been voluntarily removing trans fats. 
Some states and cities have passed trans fat bans. 
 Getting enough dietary EPA and DHA is important too, but should the fatty acids be from 
fish or fish oil? The FDA recommends that you eat 2 servings of fish per week. Fish is an 
excellent source of protein, vitamins, and trace elements (He, 2009). It is a great substitute 
for red meat, which has more saturated fats. However, contaminants in fish are also an 
important issue. For most people, the benefits of eating fish outweigh the possible risks. But 
children and women who are trying to become pregnant, are pregnant, or are nursing will 
want to avoid fish that have high contaminants, but should make sure that they have enough 
EPA and DHA from other fish or from fish oil.  
D. Strengths and Limitations 
This dissertation has several strengths. First, we used serum fatty acids, an objective 
measure that does not rely on participant report of intake, to characterize the exposure. 
Compared with measurement of serum fatty acids, measurement of fatty acid intake is 
subject to considerable random error, as well as systematic error. The effect of systematic 
error – individuals with high fat intake and high risk of ischemic stroke being more likely to 
underreport fat intake – is to bias associations toward the null. Measurement of fatty acid 
concentrations in tissue may have less systematic error, which may increase our capability 
to detect associations with ischemic stroke. In addition, our use of serum fatty acids allowed 
us to examine individual fatty acids in relation to ischemic stroke. We added to the literature 
on serum trans fatty acids, which have not been well characterized in previous correlations 
studies and ischemic stroke studies. Second, ischemic strokes were classified by etiology. 
Few studies have the brain imaging data needed to classify ischemic strokes subtypes or 
central adjudication by trained neurologist. This classification allowed us to hypothesize 
about the mechanism linking serum fatty acids and ischemic stroke. Third, our study has 
over 7 times the number of ischemic strokes in previously the largest case-control studies 
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and twice the number of ischemic strokes in previous cohort studies. This substantial 
increase in statistical power may have further increased our ability to detect associations 
with serum fatty acids. Our use of the matched case-control study design also increased 
statistical efficiency. In addition, this dissertation included the largest number of participants 
in a study examining the correlations between serum fatty acids and fatty acid intakes, 
allowing us to examine correlations in specific subgroups of postmenopausal women. 
Finally, this dissertation was conducted among a cohort of postmenopausal women who 
have been understudied in previous ischemic stroke studies. 
We also acknowledge the limitations of this dissertation. First, serum fatty acids are not 
free of measurement error. The stability of serum fatty acids during storage and freeze/thaw 
procedures was of concern. However, serum storage for up to 12 years at -80°C preserved 
polyunsaturated fatty acids from oxidation very well (Zeleniuch-Jacquotte et al., 2000). We 
conducted an analysis of 15 samples that demonstrated that there were no substantial 
changes in the composition of the serum fatty acids analyzed originally in 2005, one year 
later in 2006, and then after an additional freeze/thaw procedure. No statistically significant 
differences were detected between the mean values of the fatty acids from the original and 
one-year or freeze/thaw samples. Polyunsaturated fatty acids, the most susceptible fatty 
acids to storage and freeze/thaw, gave the best results according to this analysis.  
The second concern involves the TOAST criteria for categorizing ischemic strokes by 
etiology. Ohira and colleagues noted that more than half of previous studies examining 
ischemic stroke subtypes included hypertension or diabetes in their definition of lacunar 
stroke, obviously making these risk factors more common among patients with lacunar 
stroke (Ohira et al., 2006). This bias could, in part, explain the association between serum 
fatty acid and lacunar stroke, assuming that serum fatty acids act through hypertension to 
increase risk of ischemic stroke. Ohira and colleagues have advocated the use of a “risk 
factor-free classification” to avoid classification bias. However, the prevalence of 
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hypertension among the ischemic stroke subtypes was relatively uniform (72% of 
atherothrombotic, 73% of lacunar, and 68% of cardioembolic stroke cases) suggesting that 
this misclassification was not a major source of bias in this study. In addition, the strict 
TOAST guidelines improve the specificity of three main ischemic stroke subtypes, but they 
also limit statistical power to examine those categories. We had the lowest power to 
examine atherothrombotic stroke. However, the number of atherothrombotic strokes in this 
dissertation exceeded the total number of ischemic strokes in several previous studies.  
We are also concerned about not controlling for important confounders. In a matched 
case-control study where the inclusion of a case-control pair depends on both having 
complete covariate data, we were careful to add only variables that were justified and 
necessary to maximize statistical power. In any observational study, the possibility of 
residual confounding by some unknown factors cannot be excluded.  
Another concern is that our study population of mostly non-Hispanic Caucasian, 
postmenopausal US women is relatively homogenous, limiting generalizability to other 
populations. Correlations between biomarkers of serum fatty acids and intake may vary by 
population, likely due to the distribution of serum fatty acids or fatty acid intakes in those 
populations. These results emphasize the importance of examining the correlations of fatty 
acids biomarkers and intake in various populations. Despite the variation in correlations 
across studies, trans and marine n3 polyunsaturated fatty acids consistently have the 
highest correlations between intake and biomarker measurements. There is limited evidence 
that the association between fatty acids and ischemic stroke may be modified by participant 
age (Tilvis et al., 1987) and type of biomarker (He et al., 2007). However, these results were 
obtained in studies with a small number of ischemic stroke and the apparent modification 
may disappear in larger studies with more stable estimates of the association between fatty 
acid biomarkers and ischemic stroke.  
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E. Conclusion 
 In aim 1, we found moderate correlations between serum DHA, EPA and 18:1t fatty acid 
and their corresponding fatty acid intakes. These correlations suggest that studies 
examining the associations between serum DHA, EPA, and 18:1t fatty acid and disease 
should be consistent with studies examining the association between intake of these fatty 
acids and disease. In addition, these correlations suggest that studies that find associations 
between serum DHA, EPA, and 18:1 fatty acid and disease may make cautious dietary 
recommendations based on their results. 
 In aim 2, we found that serum linelaidic, palmitic, and oleic acids were positively 
associated with total ischemic stroke, while serum EPA, DPA, DHA, and arachidonic acids 
were inversely associated. These associations were generally consistent for 
atherothrombotic and lacunar stroke, but not cardioembolic stroke. The associations 
between these fatty acids and atherothrombotic and lacunar strokes were generally 
consistent with fatty acid intake and CHD studies. These findings highlight the importance of 
individual fatty acids in the development of particular subtypes of ischemic stroke.  
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APPENDIX I: TABLES 
 
Table 1. Trial of ORG 10172 in Acute Stroke Trial (TOAST) classification of subtypes 
of acute ischemic stroke (Adams et al., 1993). 
 
Atherothrombosis 
Cardioembolism 
Lacunae 
Other Determined Etiology 
Undetermined Etiology 
   Two or more causes identified 
   Negative evaluation 
   Incomplete evaluation 
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Table 2. Characteristics of Women’s Health Initiative Observational Study (WHI-OS) 
women (1993-1998) and US women age 50-79 (1999-2000). 
 
 WHI-OS Women US women age 50-79 
Total N 93,676 1,003 
Age group, %   
   50 to 59 31.7 42.2 
   60 to 69 44.0 33.6 
   70 to 79 24.3 24.2 
Race/ethnicity, %   
   White 83.3 74.1 
   Black 8.2 9.1 
   Hispanic 3.9 12.4 
   Other 16.6 4.4 
Education, %   
   Did not complete high school 5.2 32.9 
   High school/GED 16.3 30.3 
   Some training after high school 36.5 23.8 
   College graduate 42.0 13.4 
Family income, %   
   <$20,000 16.1 37.4 
   $20,000 to <$35,000 23.3 22.4 
   $35,000 to <$75,000 40.3 28.1 
   ≥$75,000 20.3 12.1 
Body mass index category, kg/m2, 
% 
  
   <18.5 1.2 1.1 
   18.5 to <25 39.6 29.2 
   25 to <30 34.0 30.8 
   ≥30 25.2 39.0 
Current smoker, % 6.3 36.7 
Hormone therapy use ever, % 59.5 48.8 
Hypertension, % 33.5 60.6 
 
*NHANES (Nutritional Health and Nutrition Examination Survey) 1999-2000 results 
weighted to obtain estimates for US women ages 50-79. 
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Table 3. Women’s Health Initiative (WHI) baseline data collection procedures. 
 
Self-administered forms Interviews Clinical measurement 
Personal information 
Medical history 
Personal habits 
Food questionnaire 
Hormone use 
Current medications 
Blood pressure 
Height and weight 
Blood specimen 
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Table 4. Serum fatty acids and their common names. 
 
Fatty acids Common name 
TFA  
   16:1t Palmitelaidic Acid 
   18:1t (none) 
   18:2tt Linelaidic Acid 
SFA  
   14:0 Myristic Acid 
   15:0 Pentanoic Acid 
   16:0 Palmitic Acid 
   17:0 Margaric Acid 
   18:0 Stearic Acid 
MUFA  
   16:1n7 7-Hexadecenoic Acid 
   18:1n7 Vaccenic Acid 
   18:1n9 Oleic Acid 
   20:1n9 Eicosenoic Acid 
   24:1 Nervonic Acid 
PUFA  
   18:3n3 Alpha-linolenic Acid 
   20:4n3 Eicosatetraenoic Acid 
   20:5n3 Eicosapentaenoic Acid (EPA) 
   22:5n3 Docosapentaenoic Acid (DPA) 
   22:6n3 Docosahexaenoic Acid (DHA) 
   18:2n6 Linoleic Acid 
   18:3n6 Gamma-linolenic Acid 
   20:2n6 Eicosadienoic Acid 
   20:3n6 Dihomo-gamma-linolenic Acid 
   20:4n6 Arachidonic Acid 
   22:4n6 Adrenic Acid 
   22:5n6 Osbond Acid 
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Table 5. Fatty acid intakes and selected food groups rich in fat derived from the 
Women’s Health Initiative Food Frequency Questionnaire (WHI FFQ). 
 
Nutrients (per day) Food groups (servings/day) 
Trans fatty acid 18:1, g 
Trans fatty acid 18:2, g 
 
Saturated fatty acid 14:0, g 
Saturated fatty acid 16:0, g 
Saturated fatty acid 17:0, g 
Saturated fatty acid 18:0, g 
 
Monounsaturated fatty acid 16:1, g 
Monounsaturated fatty acid 18:1, g 
Monounsaturated fatty acid 20:1, g 
 
Polyunsaturated fatty acid 18:2, g 
Polyunsaturated fatty acid 18:3, g 
Polyunsaturated fatty acid 20:4, g 
Polyunsaturated fatty acid 20:5, g 
Polyunsaturated fatty acid 22:5, g 
Polyunsaturated fatty acid 22:6, g 
Red meat 
Ground meat 
Beef, pork, or lamb 
 
Fish 
Dark fish 
White fish 
Tuna 
Shellfish 
Fried fish 
 
Poultry 
Eggs 
Dairy 
Milk 
Nuts 
Chips 
Added fat 
Butter 
Pastries 
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Table 6. Conditional logistic regression models of the odds of ischemic stroke 
according to a 1-standard deviation increment in serum fatty acid concentration. 
 
Model 1a Ischemic stroke = 1-SD Fatty acid 
Model 2b Ischemic stroke = 1-SD Fatty acid + Confounders 
Model 3c Ischemic stroke = 1-SD Fatty acid + Confounders + Blood pressure 
Model 4d Ischemic stroke = 1-SD Fatty acid + Confounders + Blood pressure + Serum 
cholesterol 
 
a Unadjusted models accounted only for the matching factors: age, race, and time on 
follow-up. 
b
 Confounders: BMI status (<25.0, 25.0 to 29.9, ≥30.0 kg/m2), smoking status (never, past, 
current), diabetes (yes, no), and aspirin use (yes, no) 
Blood pressure variables: systolic blood pressure (continuous) and antihypertensive 
medication use (yes, no) 
Serum cholesterol variables: total cholesterol to HDL-C ratio (continuous) and log 
normalized-triglycerides (continuous) 
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Table 7. Characteristics of the correlations paper study population.a 
 
Characteristic N (%) 
N 925 
Age, y  
   Mean (SD) 69 (6) 
   50-59 91 (10) 
   60-69 369 (40) 
   70-79 465 (50) 
Race/ethnicity  
   White (not of Hispanic origin) 803 (87) 
   Black or African-American 69 (7) 
   Hispanic/Latino 16 (2) 
   Asian or Pacific Islander  21 (2) 
   American Indian or Alaskan Native 4 (<1) 
   Other 10 (1) 
Education, y  
   ≤12 211 (23) 
   13-15 343 (37) 
   ≥16 368 (40) 
Household income, $  
   <35,000 408 (44) 
   35,000 – 74,999 327 (35) 
   ≥75,000 119 (13) 
Body mass index, kg/m2  
   Mean (SD) 27 (5) 
   <30 375 (41) 
   30 to <35 328 (35) 
   ≥35 209 (23) 
Current smoker 32 (3) 
Diabetesb 69 (7) 
Hypertensionc 432 (47) 
Mean baseline daily intake (SD)  
   Energy, kcal 1550 (587) 
   Fat, g 53 (28) 
   Fat, % energy 30 (8) 
   Carbohydrates, g 202 (78) 
   Carbohydrates, % energy 53 (9) 
   Protein, g 65 (27) 
   Protein, % energy 17 (3) 
 
aData are N (%), unless specified otherwise. Percentages may not add to 100% because of 
rounding and missing values. 
bDiabetes was defined as having a fasting plasma glucose level ≥ 126 mg/dL or report of a 
diagnosis of sugar diabetes.  
cHypertension was defined as having a systolic or diastolic blood pressure equal to or 
greater than 140 and 90 mm Hg, respectively, or report of use of antihypertensive 
medication. 
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Table 8. Correlations between serum DHA, EPA, and 18:1t and their corresponding 
fatty acid intakes by subgroups. 
 
 DHA EPA 18:1t 
Overall 0.53 0.42 0.39 
    
Age group, y    
   50 to 59 0.44 0.38 0.52 
   60 to 69 0.53 0.40 0.34 
   70 to 79 0.54 0.45 0.40 
   P for differencea 0.52 0.60 0.16 
    
Race    
   White 0.56 0.42 0.41 
   Black 0.22 0.32 0.09 
   P for difference 0.001 0.37 0.007 
    
Education, y    
   <12 0.41 0.36 0.28 
   13-15 0.52 0.41 0.36 
   ≥16 0.55 0.43 0.39 
   P for difference 0.10 0.63 0.36 
    
Household income, $    
   <35,000 0.47 0.32 0.33 
   35,000 to <75,000 0.53 0.41 0.33 
   ≥75,000 0.44 0.39 0.39 
   P for difference 0.43 0.36 0.79 
    
BMI, kg/m2    
   <25 0.59 0.45 0.45 
   25 to <30 0.49 0.40 0.34 
   ≥30 0.41 0.38 0.30 
   P for difference 0.02 0.46 0.08 
 
aP for difference calculated using Fisher’s z transformation. 
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Table 9. Agreement between quintiles of serum fatty acids and fatty acid intakes. 
 
 Percent Agreementa Weighted Kappab 
TFA   
   16:1t 19 -0.04 
   18:1t 30 0.25 
   18:2tt 21 0.07 
SFA   
   14:0 24 0.10 
   16:0 24 0.10 
   17:0 21 0.05 
   18:0 21 0.04 
MUFA   
   16:1n7 24 0.11 
   18:1n9 21 0.02 
   20:1n9 19 -0.05 
N3 PUFA   
   18:3n3 25 0.13 
   20:5n3 28 0.26 
   22:5n3 22 0.11 
   22:6n3 34 0.35 
N6 PUFA   
   18:2n6 20 0.04 
   20:4n6 21 0.04 
 
aProportion of participants who were ranked in the same quintile for serum fatty acids and 
fatty acid intakes. 
b
 The weighted kappa represents agreement when agreement due to chance is discounted. 
It is used for ordered categories and assigns less weight to agreement as categories are 
further apart. Kappa<0.00, 0.00 to 0.20, and 0.21 to 0.40 represents less than chance 
agreement, slight agreement, and fair agreement, respectively (Viera & Garrett, 2005). 
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Table 10. Spearman rank correlation coefficients between serum fatty acids and fatty 
acid intake groups. 
 
Serum Intake 
 TFA SFA MUFA PUFA N3 PUFA N6 PUFA 
TFA       
   16:1t -0.04 -0.10 -0.03 0.11 0.09 0.10 
   18:1t 0.39 0.02 0.15 -0.06 -0.27 0.00 
   18:2tt 0.14 0.08 0.04 -0.10 -0.19 -0.05 
SFA       
   14:0 -0.06 0.14 -0.15 -0.03 -0.02 -0.03 
   15:0 -0.05 0.24 -0.12 -0.16 -0.12 -0.15 
   16:0 -0.08 0.12 -0.18 -0.03 0.02 -0.04 
   17:0 0.02 0.07 -0.02 -0.06 -0.02 -0.07 
   18:0 0.00 0.02 -0.03 -0.02 0.00 -0.02 
MUFA       
   16:1n7 -0.10 0.14 -0.18 -0.08 0.02 -0.09 
   18:1n7 -0.08 0.01 -0.07 -0.03 0.12 -0.07 
   18:1n9 0.03 0.04 0.04 -0.07 -0.06 -0.06 
   20:1n9 0.09 0.08 0.06 -0.11 -0.20 -0.07 
   24:1n9 0.02 0.01 0.02 -0.01 0.04 -0.03 
N3 PUFA       
   18:3n3 -0.06 -0.19 0.04 0.21 0.20 0.19 
   20:4n3 -0.17 0.02 -0.08 0.01 0.13 -0.03 
   20:5n3 -0.24 -0.03 -0.10 0.07 0.29 -0.01 
   22:5n3 -0.12 0.03 -0.05 -0.01 0.11 -0.05 
   22:6n3 -0.20 -0.12 -0.06 0.13 0.33 0.06 
N6 PUFA       
   18:2n6 0.09 -0.13 0.16 0.08 -0.02 0.11 
   18:3n6 0.01 -0.03 -0.03 0.05 -0.01 0.06 
   20:2n6 -0.02 -0.09 0.02 0.09 0.04 0.09 
   20:3n6 -0.02 0.10 -0.06 -0.09 -0.10 -0.08 
   20:4n6 0.04 0.03 0.04 -0.08 -0.10 -0.07 
   22:4n6 0.03 0.03 -0.01 -0.04 -0.09 -0.01 
   22:5n6 0.11 0.10 0.03 -0.12 -0.21 -0.08 
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Table 11. Spearman rank correlation coefficients between serum fatty acids and selected food groups rich in fat. 
 Red meat Fish 
 Overall Ground 
meat 
Pork, beef, 
or lamb Overall Dark fish White fish Tuna Shellfish Fried fish 
TFA          
   16:1t -0.10 -0.06 -0.11 0.05 0.07 0.05 0.07 -0.04 -0.12 
   18:1t 0.15 0.13 0.06 -0.21 -0.26 -0.18 -0.09 -0.18 0.14 
   18:2tt 0.09 0.12 0.06 -0.14 -0.18 -0.09 -0.05 -0.04 0.04 
SFA          
   14:0 0.05 0.02 0.08 0.04 -0.01 0.03 0.04 0.05 -0.06 
   15:0 0.03 0.02 0.03 -0.04 -0.01 -0.02 0.02 -0.01 -0.05 
   16:0 0.02 -0.01 0.04 0.12 0.07 0.04 0.07 0.09 -0.05 
   17:0 -0.03 0.01 -0.02 0.02 0.04 0.01 0.03 -0.05 0.00 
   18:0 0.01 0.00 0.04 0.03 -0.04 0.02 -0.01 0.02 0.06 
MUFA          
   16:1n7 0.02 0.00 0.06 0.10 0.07 0.10 0.06 0.06 -0.13 
   18:1n7 -0.08 -0.07 -0.07 0.10 0.15 0.12 0.03 0.02 -0.12 
   18:1n9 0.06 0.01 0.04 -0.05 -0.02 -0.04 -0.07 -0.02 -0.01 
   20:1n9 0.11 0.10 0.09 -0.13 -0.17 -0.07 -0.05 0.01 0.02 
   24:1n9 0.00 0.01 -0.01 0.07 0.04 0.08 0.07 -0.01 0.01 
N3 PUFA          
   18:3n3 -0.11 -0.05 -0.11 0.06 0.11 0.08 0.09 0.00 -0.02 
   20:4n3 -0.09 -0.08 -0.02 0.12 0.13 0.12 0.08 0.08 -0.14 
   20:5n3 -0.17 -0.14 -0.07 0.35 0.40 0.29 0.16 0.20 -0.13 
   22:5n3 -0.10 -0.06 -0.07 0.10 0.17 0.11 0.05 0.05 -0.10 
   22:6n3 -0.27 -0.22 -0.18 0.39 0.47 0.31 0.21 0.17 -0.11 
N6 PUFA          
   18:2n6 0.00 0.02 -0.03 -0.12 -0.12 -0.08 -0.05 -0.06 0.10 
   18:3n6 0.03 0.00 0.05 -0.01 -0.03 -0.02 0.02 -0.05 -0.04 
   20:2n6 -0.15 -0.08 -0.09 -0.05 -0.01 -0.02 0.00 -0.05 -0.08 
   20:3n6 0.06 0.06 0.08 -0.08 -0.09 -0.05 -0.02 -0.05 -0.07 
   20:4n6 0.08 0.08 0.05 -0.07 -0.08 -0.04 -0.04 -0.04 0.05 
   22:4n6 0.06 0.08 0.04 -0.13 -0.14 -0.11 -0.07 -0.04 0.00 
   22:5n6 0.11 0.08 0.08 -0. 26 -0.23 -0.19 -0.13 -0.15 0.01 
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Table 11 (continued). Spearman rank correlation coefficients between serum fatty acids and selected food groups rich in fat. 
 Poultry Eggs Dairy Milk Added fata Butter Pastries Chips Nuts 
TFA          
   16:1t 0.05 -0.11 0.11 0.04 -0.15 -0.10 -0.09 -0.13 0.00 
   18:1t -0.06 0.03 -0.01 0.08 0.22 0.26 0.30 0.19 0.00 
   18:2tt -0.02 0.04 0.04 0.06 0.10 0.05 0.12 0.07 -0.01 
SFA          
   14:0 0.04 0.03 0.20 0.05 0.05 0.09 0.00 0.04 0.03 
   15:0 0.01 0.04 0.16 0.10 0.04 0.09 0.09 -0.02 0.03 
   16:0 0.10 0.04 0.17 0.01 -0.02 -0.01 -0.09 -0.02 0.00 
   17:0 -0.01 -0.01 0.08 0.04 -0.04 -0.02 0.03 -0.05 -0.01 
   18:0 -0.02 0.03 -0.09 -0.06 0.03 -0.04 0.03 0.07 -0.06 
MUFA          
   16:1n7 0.07 -0.01 0.18 0.06 -0.07 -0.05 -0.11 -0.11 -0.06 
   18:1n7 0.06 -0.08 0.09 0.01 -0.17 -0.17 -0.17 -0.21 -0.15 
   18:1n9 0.00 -0.03 0.03 0.01 0.00 -0.01 -0.03 -0.04 -0.02 
   20:1n9 -0.05 0.02 0.03 0.01 0.10 0.06 0.09 0.10 0.02 
   24:1n9 0.08 -0.02 0.04 0.04 -0.02 -0.03 -0.01 -0.07 -0.04 
N3 PUFA          
   18:3n3 0.01 -0.03 0.01 -0.03 -0.09 0.01 -0.01 -0.05 0.02 
   20:4n3 0.05 -0.06 0.10 0.03 -0.12 -0.10 -0.07 -0.14 -0.02 
   20:5n3 0.10 -0.08 0.06 -0.01 -0.20 -0.15 -0.16 -0.21 -0.06 
   22:5n3 0.06 -0.11 0.06 0.00 -0.13 -0.11 -0.08 -0.15 -0.08 
   22:6n3 0.11 -0.08 -0.01 -0.04 -0.24 -0.22 -0.17 -0.26 -0.05 
N6 PUFA          
   18:2n6 -0.13 0.03 -0.16 -0.04 0.09 0.11 0.12 0.11 0.08 
   18:3n6 0.00 -0.05 0.04 0.08 0.00 0.02 0.06 0.04 0.01 
   20:2n6 -0.07 -0.11 0.02 -0.04 -0.09 -0.06 -0.03 -0.07 0.07 
   20:3n6 0.01 -0.04 0.12 0.06 -0.03 -0.01 0.00 0.01 0.00 
   20:4n6 0.07 -0.01 -0.05 0.02 -0.01 -0.06 0.03 -0.02 -0.05 
   22:4n6 -0.03 -0.02 0.04 0.04 0.08 0.02 -0.02 0.07 0.04 
   22:5n6 -0.02 0.04 0.03 0.06 0.03 -0.02 0.05 0.03 -0.02 
 
aFat (butter, margarine, sour cream, oils, or other fat) added to vegetables, beans, rice, and potatoes after cooking. 
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Table 12. Baseline characteristics of the ischemic stroke paper study population by 
ischemic stroke case and control status. 
 
 Non-case Case 
N 964 964 
   
Age, yr 68.7 (6.4) 68.7 (6.4) 
   
Race   
   African American 79 (8) 79 (8) 
   Native American 5 (1) 5 (1) 
   Asian 21 (2) 21 (2) 
   Hispanic 20 (2) 20 (2) 
   White 826 (86) 826 (86) 
   Other 10 (1) 10 (1) 
   
Education   
   ≤ High school/ GED 226 (24) 235 (25) 
   Some college/ training 358 (37) 391 (41) 
   College graduate 377 (39) 330 (35) 
   
Family income   
   <$35,000 427 (48) 479 (54) 
   $35,000 to $74,999 332 (38) 302 (34) 
   ≥$75,000 126 (14) 114 (13) 
   
Moderate/strenuous  
activities ≥20 minutes* 
  
   None 121 (13) 149 (16) 
   Some 356 (37) 419 (44) 
   2-4 episodes/wk 198 (21) 160 (17) 
   >4 episodes/wk 282 (29) 225 (24) 
   
Alcohol intake   
   Non-drinker 111 (12) 117 (12) 
   Past drinker 177 (18) 211 (22) 
   <7 drinks/wk 559 (58) 511 (53) 
   ≥7 drinks/wk 116 (12) 122 (13) 
   
Blood pressure, mm Hg   
   Systolic* 130 (18) 137 (20) 
   Diastolic* 74 (10) 75 (10) 
   Hypertension* 450 (47) 647 (67) 
   
Serum lipids, mg/dL   
   Total cholesterol 231 (38) 233 (39) 
   HDL-C* 60 (16) 57 (16) 
   LDL-C 139 (37) 141 (37) 
  89
   Triglycerides* 161 (80) 180 (90) 
   Total cholesterol to HDL-C ratio* 4.2 (1.4) 4.4 (1.5) 
   
BMI, kg/m2*   
   Mean 27.0 (5.3) 27.7 (5.9) 
   < 25.0 388 (41) 330 (35) 
   25.0 to 29.9 342 (36) 365 (38) 
   ≥30.0 221 (23) 260 (27) 
   
Smoking status*   
   Never 523 (55) 501 (53) 
   Past 397 (42) 374 (39) 
   Current 36 (4) 78 (8) 
   
Comorbidities   
   Diabetes* 72 (7) 153 (16) 
   Atrial fibrillation* 55 (6) 92 (10) 
   Angina* 53 (6) 90 (9) 
   Revascularization* 11 (1) 38 (4) 
   
Medications   
   Aspirin* 238 (25) 295 (31) 
   Antihypertensive* 319 (33) 449 (47) 
   Lipid-lowering 157 (16) 182 (19) 
   Statins 83 (9) 92 (10) 
   HRT 363 (38) 381 (40) 
 
GED, General Equivalency Diploma; BMI, body mass index; HRT, hormone replacement 
therapy 
*McNemar’s chi-square or paired Student’s t test P ≤ 0.05, as appropriate. 
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Table 13. Composition of serum fatty acids.a 
 
 Non-case Case  
 Q1 Median Q3 Q1 Median Q3 Diffb 
18:2n6 24.22 27.12 30.40 23.78 26.73 29.70 *-0.55 
16:0 22.07 23.77 25.77 22.56 24.37 26.44 * 0.65 
18:1n9 16.12 17.59 19.07 16.66 18.17 19.68 * 0.46  
18:0 7.83 8.54 9.18 7.67 8.42 9.20 -0.06 
20:4n6 7.02 8.27 9.67 6.63 8.01 9.43 *-0.31 
16:1n7 1.65 2.23 2.96 1.79 2.34 3.09 * 0.15 
20:3n6 1.71 2.05 2.40 1.75 2.03 2.34 -0.01 
22:6n3 1.50 1.97 2.65 1.34 1.75 2.32 *-0.26 
18:1n7 1.29 1.47 1.69 1.31 1.49 1.68 0.01 
14:0 0.64 0.84 1.09 0.66 0.89 1.14 * 0.06 
18:1t 0.56 0.75 1.03 0.60 0.80 1.05 * 0.05 
20:5n3 0.44 0.60 0.85 0.40 0.56 0.76 *-0.09 
22:5n3 0.45 0.56 0.68 0.41 0.51 0.63 *-0.05 
18:3n3 0.44 0.55 0.68 0.42 0.53 0.66 *-0.02 
18:3n6 0.32 0.41 0.53 0.31 0.41 0.52 -0.01 
16:1t 0.27 0.33 0.38 0.28 0.33 0.39 0.001 
22:4n6 0.15 0.30 0.43 0.15 0.29 0.42 -0.005 
17:0 0.25 0.28 0.32 0.24 0.28 0.32 -0.003 
20:2n6 0.22 0.26 0.30 0.22 0.25 0.30 -0.004 
22:5n6 0.19 0.25 0.32 0.19 0.24 0.31 *-0.012 
15:0 0.15 0.19 0.23 0.15 0.19 0.23 0.003 
20:1n9 0.09 0.14 0.24 0.10 0.14 0.26 0.004 
20:4n3 0.05 0.08 0.11 0.05 0.07 0.10 *-0.004 
18:2tt 0.02 0.03 0.06 0.02 0.04 0.07 * 0.005 
24:1n9 0.00 0.00 0.04 0.00 0.00 0.05 -0.004 
 
Q, quartile; Diff, difference; t, trans. 
aFatty acids are shown in order of contribution to total serum fatty acids. 
bThe average of the differences between case and control serum fatty acid concentration. 
*Paired t test P ≤ 0.05. 
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Table 14. Odds ratios and 95% confidence intervals for total ischemic stroke associated with a 1-standard deviation 
increase in individual serum fatty acids. 
 
Fatty Acid SD Model 1 Model 2 Model 3 Model 4 
TFA      
   16:1 t 0.10 1.02 (0.93, 1.11) 0.996 (0.91, 1.09) 1.02 (0.92, 1.13) 0.94 (0.83, 1.07) 
   18:1 t 0.40 1.15 (1.05, 1.27) 1.13 (1.02, 1.25) 1.13 (1.02, 1.25) 1.12 (1.01, 1.24) 
   18:2 t 0.04 1.39 (1.19, 1.63) 1.38 (1.17, 1.63) 1.34 (1.13, 1.59) 1.27 (1.06, 1.51) 
SFA      
   14:0 0.36 1.21 (1.10, 1.34) 1.18 (1.06, 1.31) 1.16 (1.04, 1.29) 1.09 (0.94, 1.25) 
   15:0 0.06 1.09 (0.97, 1.21) 1.10 (0.98, 1.24) 1.11 (0.98, 1.25) 1.07 (0.94, 1.21) 
   16:0 2.74 1.31 (1.19, 1.45) 1.27 (1.14, 1.41) 1.23 (1.10, 1.37) 1.23 (1.07, 1.41) 
   17:0 0.06 0.94 (0.86, 1.04) 0.97 (0.88, 1.07) 1.001 (0.90, 1.11) 1.01 (0.91, 1.12) 
   18:0 1.11 0.93 (0.84, 1.03) 0.92 (0.83, 1.03) 0.93 (0.83, 1.03) 0.99 (0.87, 1.11) 
MUFA      
   16:1 n7 1.01 1.17 (1.06, 1.28) 1.15 (1.05, 1.27) 1.13 (1.02, 1.25) 1.09 (0.97, 1.22) 
   18:1 n7 0.32 1.03 (0.94, 1.12) 1.03 (0.94, 1.14) 1.05 (0.95, 1.15) 1.03 (0.93, 1.14) 
   18:1 n9 2.32 1.26 (1.14, 1.38) 1.20 (1.08, 1.33) 1.18 (1.06, 1.31) 1.13 (0.995, 1.27) 
   20:1 n9 0.12 1.16 (0.97, 1.38) 1.16 (0.96, 1.40) 1.12 (0.93, 1.36) 1.06 (0.87, 1.29) 
   24:1n9 0.08 0.86 (0.73, 1.02) 0.87 (0.74, 1.03) 0.88 (0.74, 1.05) 0.92 (0.78, 1.09) 
N3 PUFA      
   18:3 n3 0.22 0.87 (0.78, 0.97) 0.90 (0.80, 1.003) 0.92 (0.82, 1.03) 0.87 (0.77, 0.99) 
   20:4 n3 0.05 0.89 (0.80, 0.99) 0.92 (0.83, 1.03) 0.94 (0.84, 1.05) 0.92 (0.82, 1.03) 
   20:5 n3 0.54 0.82 (0.74, 0.91) 0.84 (0.75, 0.93) 0.88 (0.79, 0.99) 0.89 (0.80, 1.001) 
   22:5 n3 0.18 0.69 (0.62, 0.77) 0.72 (0.64, 0.80) 0.75 (0.67, 0.84) 0.75 (0.66, 0.84) 
   22:6 n3 0.91 0.70 (0.63, 0.78) 0.72 (0.64, 0.80) 0.75 (0.67, 0.84) 0.76 (0.67, 0.85) 
N6 PUFA      
   18:2 n6 4.41 0.89 (0.81, 0.97) 0.92 (0.84, 1.02) 0.94 (0.85, 1.03) 0.998 (0.89, 1.12) 
   18:3 n6 0.16 0.93 (0.85, 1.02) 0.91 (0.83, 1.01) 0.91 (0.82, 1.01) 0.89 (0.80, 0.99) 
   20:2 n6 0.06 0.94 (0.86, 1.03) 1.01 (0.91, 1.11) 1.02 (0.92, 1.13) 1.02 (0.92, 1.13) 
   20:3 n6 0.50 0.97 (0.88, 1.07) 0.97 (0.88, 1.08) 0.94 (0.85, 1.05) 0.91 (0.82, 1.02) 
   20:4 n6 2.02 0.81 (0.73, 0.90) 0.81 (0.73, 0.91) 0.82 (0.73, 0.92) 0.85 (0.75, 0.96) 
   22:4 n6 0.18 0.91 (0.77, 1.07) 0.93 (0.78, 1.10) 0.91 (0.77, 1.08) 0.92 (0.77, 1.09) 
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   22:5 n6 0.11 0.88 (0.80, 0.98) 0.88 (0.80, 0.98) 0.86 (0.77, 0.97) 0.85 (0.76, 0.96) 
 
Model 1: Unadjusted models accounted only for the matching factors: age, race, and time on follow-up. 
Model 2: Adjusted for BMI status (<25.0, 25.0 to 29.9, ≥30.0 kg/m2), smoking status (never, past, current), diabetes, and aspirin use. 
Model 3: Adjusted for the previous model variables plus systolic blood pressure and antihypertensive medication use. 
Model 4: Adjusted for the previous model variables plus total cholesterol to HDL-C ratio and normalized-triglycerides. 
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Table 15. Odds ratios and 95% confidence intervals for ischemic stroke subtypes 
associated with a 1-standard deviation increase in individual serum fatty acids. 
 
Fatty Acid Model 1 Model 2 Model 3 Model 4 
     
Atherothombotic stroke (n=96) 
   18:2t 1.83 (1.05, 3.17) 1.77 (0.91, 3.45) 1.74 (0.88, 3.43) 1.13 (0.53, 2.45) 
   16:0 1.42 (1.01, 2.00) 1.12 (0.74, 1.69) 1.10 (0.72, 1.68) 0.86 (0.48, 1.52) 
   18:1n9 1.43 (1.01, 2.04) 1.40 (0.93, 2.10) 1.41 (0.92, 2.16) 0.89 (0.50, 1.56) 
   20:5n3 0.66 (0.48, 0.92) 0.51 (0.31, 0.82) 0.47 (0.28, 0.79) 0.38 (0.20, 0.71) 
   22:5n3 0.82 (0.61, 1.10) 0.83 (0.59, 1.17) 0.86 (0.60, 1.23) 0.81 (0.55, 1.21) 
   22:6n3 0.63 (0.44, 0.88) 0.70 (0.47, 1.04) 0.65 (0.42, 1.01) 0.66 (0.40, 1.08) 
   20:4n6 0.77 (0.55, 1.07) 0.70 (0.48, 1.04) 0.66 (0.44, 0.99) 0.74 (0.48, 1.14) 
     
Lacunar stroke (n=250) 
   18:2t 1.41 (1.05, 1.90) 1.39 (1.01, 1.90) 1.38 (0.98, 1.94) 1.24 (0.89, 1.72) 
   16:0 1.22 (1.01, 1.47) 1.20 (0.98, 1.47) 1.17 (0.94, 1.46) 1.14 (0.86, 1.52) 
   18:1n9 1.26 (1.05, 1.51) 1.23 (1.01, 1.49) 1.30 (1.04, 1.63) 1.17 (0.90, 1.52) 
   20:5n3 0.56 (0.43, 0.74) 0.58 (0.44, 0.78) 0.65 (0.48, 0.87) 0.65 (0.48, 0.89) 
   22:5n3 0.61 (0.49, 0.77) 0.64 (0.51, 0.80) 0.70 (0.55, 0.89) 0.64 (0.49, 0.83) 
   22:6n3 0.60 (0.47, 0.75) 0.61 (0.48, 0.79) 0.68 (0.52, 0.88) 0.69 (0.53, 0.91) 
   20:4n6 0.76 (0.61, 0.93) 0.75 (0.60, 0.94) 0.73 (0.57, 0.92) 0.81 (0.62, 1.05) 
     
Cardioembolic stroke (n=209) 
   18:2t 0.94 (0.67, 1.33) 0.96 (0.66, 1.39) 0.85 (0.57, 1.25) 0.94 (0.62, 1.42) 
   16:0 1.19 (0.98, 1.44) 1.12 (0.91, 1.38) 1.05 (0.84, 1.31) 1.14 (0.86, 1.51) 
   18:1n9 1.30 (1.04, 1.64) 1.22 (0.96, 1.56) 1.15 (0.90, 1.49) 1.43 (1.05, 1.94) 
   20:5n3 0.85 (0.66, 1.09) 0.84 (0.65, 1.09) 0.89 (0.68, 1.15) 0.88 (0.67, 1.14) 
   22:5n3 0.80 (0.63, 1.02) 0.82 (0.64, 1.05) 0.87 (0.68, 1.12) 0.87 (0.67, 1.13) 
   22:6n3 0.67 (0.53, 0.86) 0.66 (0.51, 0.85) 0.70 (0.54, 0.91) 0.70 (0.54, 0.90) 
   20:4n6 0.85 (0.67, 1.08) 0.86 (0.67, 1.11) 0.92 (0.70, 1.20) 0.82 (0.61, 1.10) 
     
Ischemic strokes of undetermined etiology (n=366) 
   18:2t 1.51 (1.14, 1.98) 1.51 (1.13, 2.02) 1.46 (1.09, 1.97) 1.35 (1.003, 1.82) 
   16:0 1.45 (1.22, 1.73) 1.42 (1.18, 1.70) 1.39 (1.16, 1.68) 1.39 (1.10, 1.74) 
   18:1n9 1.19 (1.02, 1.38) 1.14 (0.97, 1.35) 1.13 (0.96, 1.33) 1.06 (0.88, 1.28) 
   20:5n3 0.98 (0.86, 1.11) 0.99 (0.87, 1.13) 1.02 (0.89, 1.17) 1.03 (0.90, 1.18) 
   22:5n3 0.63 (0.53, 0.77) 0.65 (0.54, 0.79) 0.67 (0.55, 0.81) 0.67 (0.55, 0.81) 
   22:6n3 0.81 (0.69, 0.96) 0.83 (0.70, 0.99) 0.85 (0.71, 1.02) 0.86 (0.72, 1.03) 
   20:4n6 0.85 (0.72, 1.01) 0.86 (0.72, 1.03) 0.88 (0.73, 1.05) 0.92 (0.76, 1.11) 
 
Model 1: Unadjusted models accounted only for the matching factors: age, race, and time on 
follow-up. 
Model 2: Adjusted for BMI status (<25.0, 25.0 to 29.9, ≥30.0 kg/m2), smoking status (never, 
past, current), diabetes, and aspirin use. 
Model 3: Adjusted for the previous model variables plus systolic blood pressure and 
antihypertensive medication use. 
Model 4: Adjusted for the previous model variables plus total cholesterol to HDL-C ratio and 
normalized-triglycerides. 
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APPENDIX II: FIGURES 
 
 
Figure 1. Mortality rates for Japanese men aged 55-64 years in California, Hawaii, and 
Japan, 1950 (Gordon, 1957; D. M. Reed, 1990). 
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Figure 2. Coronary heart disease (CHD mortality (A, r=0.66, p<0.001) and cerebrovascular 
mortality (B, r=-0.56, p<0.01) per 100,000 men and women from 21 countries, 
1990 (Renaud, 2001). 
A             B 
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Figure 3. Distribution of ischemic stroke subtypes among 438 patients enrolled in the 
Northern Manhattan Stroke Study, 1993-1997. CEMB=coronary embolism, LAC=lacunar, 
CRYPT=cryptogenic stroke, EATH=extracranial atherosclerotic stroke, IATH=intracranial 
atherosclerotic stroke, (R. L. Sacco et al., 1995) 
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Figure 4. Conceptual model of the association between serum fatty acids and ischemic 
stroke. 
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Figure 5. Composition of serum fatty acids () and fatty acid intakes (). Fatty acids are 
grouped by type and shown in order of contribution to total serum fatty acids. Data are 
medians. 
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Figure 6. (A) Unadjusted and (B) partial Spearman rank correlation coefficients between 
serum fatty acid concentrations and fatty acid intakes. Partial correlations coefficients were 
adjusted for age (continuous), race/ethnicity (white, non-white), body mass index (<25, 25 to 
<30, ≥30 kg/m2), and current smoking status (no, yes). Correlations coefficients r ≥ 0.20 
were statistically significant (P≤0.003)
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Figure 7. Odds ratios and 95% confidence intervals for total ischemic stroke associated with a 1-standard deviation increment in 
individual serum fatty acids. 
 
: Unadjusted models accounted only for the matching factors: age, race, and time on follow-up. 
: Adjusted for BMI status (<25.0, 25.0 to 29.9, ≥30.0 kg/m2), smoking status (never, past, current), diabetes, and aspirin use. 
: Adjusted for the previous model variables plus systoic blood pressure and antihypertensive medication use. 
: Adjusted for the previous model variables plus total cholesterol to HDL-C ratio and normalized-triglycerides. 
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Figure 8. Odds ratios and 95% confidence intervals for ischemic stroke subtypes associated with a 1-standard deviation increment in 
individual serum fatty acids. 
 
: Unadjusted models accounted only for the matching factors: age, race, and time on follow-up. 
: Adjusted for BMI status (<25.0, 25.0 to 29.9, ≥30.0 kg/m2), smoking status (never, past, current), diabetes, and aspirin use. 
: Adjusted for the previous model variables plus systolic blood pressure and antihypertensive medication use. 
: Adjusted for the previous model variables plus total cholesterol to HDL-C ratio and normalized-triglycerides.
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